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THE DEVELOPMENT AND APPLICATION OF 
METAL-CATALYZED DIAMINATION REACTIONS 
 
 Nitrogen-rich molecules are of great interest in chemistry and incorporation of nitrogen 
into molecules is an on-going active field of study. In particular, vicinal diamines are important 
functional moieties that are found throughout biologically active molecules and natural products 
as well as highly effective chiral control agents in organic synthesis. There has been much effort 
directed toward the efficient synthesis of vicinal diamines; however the development of a direct 
route has proven to be challenging. This dissertation discusses the application of diamination 
products from existing methods to synthesize biologically active motifs, as well as the 
development of new metal-catalyzed diamination methods for the synthesis of biologically 
interesting motifs from readily available starting materials. 
 The β,γ-diamino acid motif is an area of active research because of its prevalence in 
biologically active molecules and its use in peptide library syntheses. Cyclization of β,γ-diamino 
acids give the closely related 4-aminopyrrolidinones. These five-membered amino lactams have 
been reported to potentiate insulin activity when incorporated into hypoglycemic peptide 
analogues and made the analogues more stable towards physiological degradation. Current 
methods for the synthesis of these compounds require multi-step procedures and rely heavily on 
commercially available amino acids as starting materials, thus limiting the structural variability 
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for biological studies. Using a diamination method discovered in our lab, 4-aminopyrrolidinones 
were efficiently synthesized in 40% overall yield, over five steps from readily available terminal 
olefins or conjugated dienes, providing a comparable process in the synthesis of these 
compounds. 
 As part of our ongoing efforts to study the mechanism of metal-catalyzed diaminations 
using diaziridinone as nitrogen source, it was found that regioselectivity in the diamination of 
conjugated dienes could be controlled using Cu(I) as catalyst and varying reaction conditions. An 
alternative nitrogen source, thiadiaziridine 1,1-dioxide, which has shown to display interesting 
reactivity, was chosen to further investigate the Cu(I)-catalyzed regioselective diamination. Upon 
varying reaction conditions with Cu(I) catalysts, regioselective diamination occurred for various 
conjugated dienes and allowed direct access to a range of diverse cyclic sulfamides which have 
interesting biological potential. 
 With the racemic synthesis of cyclic sulfamides, it was of interest to obtain these 
compounds asymmetrically, as their biological properties are of value and current methods for 
their asymmetric synthesis do not allow much variation in substitution patterns. Using Pd2(dba)3 
and a chiral phosphoramidite ligand, a variety of chiral cyclic sulfamides were synthesized in 
moderate to high yields and with ee’s greater than 90%, providing direct access to these valuable 
compounds in one step from readily available conjugated diene substrates. 
 Lastly, N,N-Di-tert-butyl thiadiaziridine 1,1-dioxide has been found to be a versatile 
reagent for interesting reactivity. Other uses of this reagent include the Pd(II)-catalyzed terminal 
diamination of conjugated dienes, diamination of allenes, and the Pd-catalyzed oxidation of 
alcohols to form α,β-unsaturated compounds. 
iv 
 
TABLE OF CONTENTS 
 
ABSTRACT .................................................................................................................................... ii 
CHAPTER 1.0: VICINAL DIAMINE FUNCTIONALITY ...........................................................1 
    1.1 GENERAL INTRODUCTION ..............................................................................................1 
    1.2 METHODS TO SYNTHESIZE VICINAL DIAMINES .......................................................2 
    1.2.1 Stoichiometric Diamination ................................................................................................2 
    1.2.2 Catalytic Diamination .........................................................................................................9 
    1.2.3 Methods Inspired by Inherent Ring Strain ........................................................................18 
    1.2.3.1 Pd-Catalyzed ..................................................................................................................18 
    1.2.3.2 Cu-Catalyzed..................................................................................................................25 
    1.3 REFERENCES ....................................................................................................................29 
CHAPTER 2.0: β,γ-DIAMINO ACIDS and 4-AMINOPYRROLIDINONES .............................34 
    2.1 GENERAL INTRODUCTION ............................................................................................34 
    2.1.1 Methods to Synthesize β,γ-Diamino Acids and 4-Aminopyrrolidinones .........................35 
    2.2 RESULTS AND DISCUSSION ..........................................................................................44 
    2.2.1 Retrosynthetic Analysis ....................................................................................................44 
    2.2.2 Hydroboration ...................................................................................................................45 
    2.2.3 Oxidation to Carboxylic Acid ...........................................................................................48 
    2.2.4 Lactamization ....................................................................................................................50 
    2.3 CONCLUSION ....................................................................................................................52 
v 
 
    2.4 EXPERIMENTAL ...............................................................................................................53 
    2.5 REFERENCES ....................................................................................................................62 
CHAPTER 3.0: Cu(I)-CATALYZED REGIOSELECTIVE DIAMINATION ............................64 
    3.1 GENERAL INTRODUCTION ............................................................................................64 
    3.1.1 Regioselective Diamination Using Diaziridinone ............................................................64 
    3.1.2 Alternative Nitrogen Source and Interesting Reactivity ...................................................65 
    3.2 RESULTS AND DISCUSSION ..........................................................................................69 
    3.2.1 Reaction Conditions and Substrate Scope ........................................................................69 
    3.2.2 Mechanistic Hypothesis ....................................................................................................75 
    3.3 CONCLUSION ....................................................................................................................77 
    3.4 EXPERIMENTAL ...............................................................................................................78 
    3.5 REFERENCES ....................................................................................................................90 
CHAPTER 4.0: CATALYTIC ASYMMETRIC SYNTHESIS OF CYCLIC SULFAMIDES ....92 
    4.1 GENERAL INTRODUCTION ............................................................................................92 
    4.2 CURRENT METHODS TO SYNTHESIZE CHIRAL CYCLIC SULFAMIDES .............92 
    4.3 RESULTS AND DISCUSSION ..........................................................................................95 
    4.3.1 Reaction Conditions and Substrate Scope ........................................................................95 
    4.3.2 Mechanistic Hypothesis ..................................................................................................103 
    4.3.3 Attempt at Asymmetric Terminal Diamination ..............................................................104 
    4.4 CONCLUSION ..................................................................................................................106 
    4.5 EXPERIMENTAL .............................................................................................................107 
vi 
 
    4.6 REFERENCES ..................................................................................................................119 
CHAPTER 5.0 OTHER THIADIAZIRIDINE USES .................................................................121 
    5.1 Pd(II)-CATALYZED TERMINAL DIAMINATION .......................................................121 
    5.1.1 Background .....................................................................................................................121 
    5.1.2 Results and Discussion ...................................................................................................121 
    5.1.3 Mechanistic Hypothesis ..................................................................................................123 
    5.2 METAL-CATALYZED DIAMINATION OF ALLENES ...............................................124 
    5.2.1 Results and Discussion ...................................................................................................124 
    5.3 OXIDATION OF ALCOHOLS .........................................................................................125 
    5.3.1 Background .....................................................................................................................125 
    5.3.2 Results and Discussion ...................................................................................................126 
    5.4 CONCLUSION ..................................................................................................................130 
    5.5 REFERENCES ..................................................................................................................131 
SUPPLEMENTAL ......................................................................................................................132 
    Appendix 1 Spectra for Chapter 2 ...........................................................................................132 
    Appendix 2 Spectra for Chapter 3 ...........................................................................................168 











1.1 GENERAL INTRODUCTION 
 Nitrogen-rich molecules are of great interest in chemistry and incorporation of nitrogen 
into molecules is an ongoing active field of study. In particular, vicinal diamines are important 
functional moieties that are found throughout biologically active molecules and natural 
products.1 Such examples include antiarrhythmics, antihypertensives, antipsychotics, analgesics, 
anticonvulsants, anticancer and antiparasitic compounds (Figure 1.1). Vicinal diamines are also 
used as highly effective chiral control agents in organic synthesis (Figure 1.2).1,2 
 




Figure 1.2 Examples of Chiral Diamine Ligands and Auxiliaries 
1.2 METHODS TO SYNTHESIZE VICINAL DIAMINES 
 The introduction of dual functionality within the confines of close proximity is of 
importance in complex organic synthesis, especially when done in a stereocontrolled manner. 
There has been much effort directed toward the efficient synthesis of vicinal diamines; however 
the development of a direct route has proven to be challenging. An expedient approach to install 
vicinal diamines comes from the direct diamination of olefins, in a manner similar to that of the 
dihydroxylation reaction of alkenes using OsO4.1,3 Various processes to access vicinal diamines 
from olefins have been reported including metal-mediated, metal-catalyzed, as well as metal-free 
methods. The following chapter will highlight advances in both stoichiometric as well as 
catalytic diamination methods. 
1.2.1 Stoichiometric Diamination 
 In 1974, Barluenga and coworkers reported the addition of anilines to various alkenes in 
the presence of thallium(III) acetate to give aromatic vicinal diamines in good yields (Scheme 





 Sharpless and Singer reported imido selenium compounds for the diamination of 
conjugated dienes.6 When cyclohexadiene was used as substrate, the nitrogens were introduced 
cis to each other (Figure 1.3). Nosyl-protected imido selenium reagent was also reported.6b In the 
following year, Sharpless and coworkers reported the stereoselective syn-addition of two 
nitrogen atoms to mono- and di-substituted trans alkenes using bis- and tris-imidoosmium 
complexes (Scheme 1.2).7  Muñiz and coworkers have reported many studies on the structure 
and electronic nature of imidoosmium complexes8 and have reported moderate 








 In 1978, Bäckvall reported an aza-Wacker-type amino-palladation process, followed by 
stoichiometric oxidation of the Pd and nucleophilic displacement by an amine source (Figure 
1.4).11 Although limited to secondary amine sources, Bäckvall’s report was nevertheless a 
pioneering publication which forged the way into transition metal-mediated diamination. 
 
Figure 1.4 
 Bergman and coworkers described the diamination of a variety of cis, trans, tri- and 
tetrasubstituted alkenes using a cyclopentadienylnitrosylcobalt dimer and nitric oxide (Scheme 
1.3).12 It was proposed that addition of the nitrogen groups occurs stereoselectively, however 






 Fristad and coworkers showed in 1985 that Mn(III) species can functionalize terminal, di- 
and trisubstituted alkenes to give 1,2-diazides (Scheme 1.4).13 These were then reduced to yield 
vicinal diamines in a two-step process. It was proposed that N3 addition proceeded via a radical 
process and therefore stereoselectivity was low. 
 
Scheme 1.4 
 A report from Chemler and coworkers used stoichiometric amounts of copper(II) 
neodecanoate [Cu(ND)2] and a tethered sulfamide source of nitrogen to synthesize cyclic 
sulfamides in an intramolecular diamination reaction (Scheme 1.5).14 The reaction provides the 





 Recently, a series of styrenes were efficiently diaminated using HgO•2HBF4 and N-
protected ethylenediamine. The resulting piperazines were obtained in moderate to good yields.15 
Activation of the double bond by the mercury salt and attack of one nitrogen gives a β-
aminomercury(II)tetrafluoroborate intermediate (Scheme 1.6). Subsequent intramolecular 
cyclization generates the piperazine products. 
 
Scheme 1.6 
 Electrophilic iodine has shown to facilitate the diamination of olefins. Lavilla and 
coworkers reported the diamination of 1,4-dihydropyridines using I2 and Na2CO3 (Scheme 1.7).16  
Electrophilic interaction of the iodine with the alkene allows addition of secondary amines trans 
to each other in good yields. Iodide has also been used in conjunction with chloramine-T for the 
diamination of glycals in moderate yields.17 
 
Scheme 1.7 
 Muñiz and coworkers diaminated styrenes, in an enantioselective fashion, employing 
stoichiometric amounts of chiral iodine reagent 1-1.18 HNMs2 was selected as a suitable nitrogen 





Muñiz and coworkers also reported the diamination of conjugated dienes and trienes using 
PhI(OAc)2 and either NHTs2 or NHMs2 as nitrogen source.19 Yields were good and the 
diamination of aryl-substituted dienes resulted in 1,2-diamination, whereas alkyl-substituted 





Another electrophilic iodine source, N-iodosuccinimde (NIS), has also been used to promote 
diamination.20 Chiral 2,2’-bipyrrolidines were efficiently constructed using NIS via 
intramolecular diamination by Hennecke and coworkers (Scheme 1.9).21  The bicyclic amines 
were synthesized in good yields and proved to be an efficient route to trans-bpbp ligands. 
 
Scheme 1.9 
An in situ-generated iodine source with incorporated transferable nitrogen groups was reported 
by Muñiz and coworkers. Preformed reagent PhI(NTs2)2 is synthesized from PhI(OAc)2 and 4 
equivalents of Ts2NH (Scheme 1.10). Diamination was complete within minutes, providing high 
yields (Scheme 1.10).22 A catalytic variation using dinuclear iodine reagents was also reported 





A report from Jeffrey and coworkers employs a chlorourea for the 1,4-diamination of cyclic 
dienes via a [4+3] cycloaddition (Figure 1.6).24 The choice of base was crucial and the sodium 
alkoxide of 2,2,3,3-tetrafluoropropanol (TFP-Na) provided optimal yields. High yields were 




A number of additional intra- and intermolecular diamination methods have been reported 
including the use of other electrophilic iodine reagents25  and HOAc26 to facilitate diamination. A 
Ritter-type reaction of N-chlorosaccharin with terminal alkenes was also reported.27 
1.2.2 Catalytic Diamination 
 The above metal-mediated processes demonstrate useful approaches to obtain diamines 
but are limited by the fact that they still require stoichiometric amounts, or high loads of sub-
stoichiometric amounts of metal. Many of these methods have a limited scope and have not been 
developed enantioselectively. Metal-catalyzed diamination of olefins has seen significant 
progress in the past decade and presents a viable pathway to vicinal diamines.1-3,28 In 2001, Li 
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and coworkers reported the catalytic, electrophilic diamination of α,β-unsaturated ketones and 
esters using catalytic Rh dimer, FeCl3 or MnO2 as catalyst and TsNCl2 as nitrogen source 
(Scheme 1.11).29 The resulting imidazoline products can then be opened using acid to yield the 
protected vicinal diamines. They have also been able to execute this reaction without metal when 
using nucleophilic nitriles as nitrogen sources.30 
 
Scheme 1.11 
 Palladium(II) salts have been used as effective catalysts for the intermolecular 
diamination of conjugated dienes (Figure 1.7),31 unactivated olefins32 and allylic ethers (Scheme 
1.12),33 and β-substituted styrenes (Scheme 1.13). These processes proceed through 
aminopalladation via initial π-allyl complex formation and subsequent displacement of the 
palladium by another nitrogen source.34 High diastereoselectivity in the case of internal alkenes 













 Jørgensen and coworkers reported their efforts on the enantioselective diamination of 
α,β-unsaturated aldehydes via iminium/enamine catalysis.35 As an extension, an electrophilic 
nitrogen source (DEAD) was used to facilitate the enantioselective diamination of α,β-
unsaturated aldehydes. As shown in Scheme 1.14, upon iminium-ion activation of the aldehyde, 
succinimide adds at the β-position (1-3). DEAD attacks at the α-position of enamine 1-4 to form 
iminium 1-5 which generates the diamination product and regenerates the prolinol-derived 
catalyst (1-2). Two examples were given and E-dec-2-enal was effectively diaminated  in 39% 





 Intramolecular diamination in which the two nitrogen atoms are tethered to a terminal 
olefin was reported by Muñiz and coworkers in 2005 using Pd(II) as catalyst.36,37 Syn-
aminopalladation occurs initially, followed by oxidation and nucleophilic replacement of the 
palladium by the second nitrogen (Figure 1.8). A variety of bicyclic ureas can be obtained in 
good to high yields. Extensions of this reaction include the synthesis of bisindolines, 
bispyrrolidines38 and diamine carboxylic esters with high diasteroselectivity.39  A Au(I)-
catalyzed variation40 as well as a Ni(II)-catalyzed variation via sulfamide transfer have also been 
reported.41 Along with PhI(OAc)2 as oxidant, CuBr2 and CuCl have also been reported to be 
effective oxidants to regenerate the active catalyst.42 Interestingly, a metal-free Br-catalyzed 
intramolecular diamination of terminal alkenes and acrylates was reported by Muñiz and 
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coworkers in 2012.43 KBr is used as catalyst and the economical NaClO2 as terminal oxidant. 
Both terminal alkenes and acrylates are efficiently diaminated in high yields and in up to 4:1 dr 








Broggini and coworkers recently reported a mechanistically similar reaction of Pd(II)-catalyzed 
diamination of alkenylureas to form bicyclic piperazinones (Scheme 1.15).44  Variation on the 
nitrogen protecting groups tolerated electron-rich and electron-poor groups and the resulting 
bicyclic piperazinones were obtained in good yields. 
 
Scheme 1.15 
 Through an interesting mechanism, Chiba and coworkers reported intramolecular Cu(I)-
catalyzed aerobic [3+2]-annulation of N-alkenyl amidines for an overall diamination of tethered 
alkenes (Scheme 1.16).45  One-electron oxidation of amidine 1-6 via diazaenolate 1-7 gives 
radical 1-8; which upon further oxidation generates nitrene intermediate 1-9. The authors 
propose the alternative resonance form 1-10 then undergoes concerted [3+2]-annulation. The 
resulting bicyclic amidines were obtained in moderate to high yield, retaining the geometry of 





 Michael and coworkers reported a related diamination of amide-tethered terminal alkenes 
using N-fluorobenzenesulfonimide (NFSI) as an electrophilic nitrogen source (Scheme 1.17).46 
Aminopalladation followed by oxidative addition of NFSI gives a Pd(IV) intermediate 
whereupon reductive elimination, yields the diamine product.46b  This process has been made 





Xiong, Li, Zhang and coworkers developed an intermolecular diamination of substituted styrenes 
using NFSI as oxidant, Cu(OTf)2 as catalyst and a second nitrogen source (Scheme 1.18).48 
Electron-poor styrenes proved most reactive and yields were mostly above 80%. 
 
Scheme 1.18 
 Nevado and de Haro reported in 2011 the oxidative difunctionalization of unactivated 
alkenes wherein gold catalyzed the diamination of terminal alkenes.49 Amine-tethered terminal 
olefins underwent an aminoamidation reaction to yield the diamine products in good yields 
(Scheme 1.19). Six-membered rings were the favored formation and the authors’ findings 
propose that multiple mechanisms coexist.  
 
Scheme 1.19 
 Intramolecular dihydroamination of allenes was reported by Widenhoefer and coworker 
using 5 mol% Au-carbene complex and AgPF6 (Scheme 1.20).50  Activation of the allene by gold 
(1-12) and intramolecular attack of the first nitrogen closes the ring which upon proton 
transfer/protodeauration and subsequent attack of the second nitrogen (1-15) yields alkyl gold 
species 1-16. Proton transfer yielded the diamination products in good to high yields. 
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Diamination of internal as well as terminal alkynes has been reported using Cu(II)/Fe(III),51 




1.2.3 Methods Inspired by Inherent Ring Strain 
1.2.3.1 Pd-Catalyzed 
 Small rings bear attractive reactive capabilities, as they inherently possess potential 
energy which could be harnessed for a variety of chemical reactions and transformations. Shi and 
coworkers envisioned employing a strained dinitrogen-containing ring as a nitrogen source and 
utilizing a metal to insert into the N-N bond to relieve the ring strain. This complex could then 
coordinate to an unsaturated double bond, allowing insertion of the first nitrogen followed by 





This was in fact realized when Shi and coworkers reported in 2007 the regio- and stereoselective 
diamination of conjugated dienes and trienes using di-tert-butyldiaziridinone (1-17) as nitrogen 
source.54 Using Pd(PPh3)4 as catalyst, the intermolecular diamination is highly effective for a 
variety of conjugated dienes including trans, trisubstituted, electron deficient and electron-rich 
dienes in high yields and short reaction times (Figure 1.10). It was shown that the diamination 
occurred regioselectively at the internal trans double bond and was highly diastereoselective, 
with both nitrogens adding syn to the olefin, yielding the trans diamination product. When a 
mixture of E and Z isomers were subjected to the reaction conditions, only the E isomer was 
consumed and the Z isomer was left enriched. The nitrogen source di-tert-butyldiaziridinone (1-









 It was proposed that oxidative insertion of Pd(0) into the N-N bond of diaziridinone 1-17 
formed the four-membered Pd(II) complex 1-18 (Scheme 1.23). Complex 1-18 coordinates with 
the diene and after migratory insertion of one nitrogen, the π-allyl Pd complex 1-20 is generated. 






 In the same year, this reaction was expanded to effectively diaminate the allylic and 
homoallylic carbons of terminal olefins under solvent-free conditions (Figure 1.11).57 It was 
proposed that this reaction proceeded through a C-H activation mechanism (Scheme 1.24). 
Coordination of the terminal olefin 1-21 to the four-membered Pd(II) complex (1-18) gives 1-22. 
Removal of an allylic hydrogen results in π-allyl Pd complex 1-23. It is proposed that after β-H 
elimination the reactive diene 1-24 is formed in situ and is subsequently diaminated at the 
internal trans double bond according to the mechanism described for conjugated diene substrates. 








 Both of the aforementioned diamination systems have been developed asymmetrically 
using chiral ligands 1-2558 and 1-2659 respectively (Figure 1.12).60 The steric bulkiness of the 
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amine substituent played a large role in reactivity and enantioselectivity of the diamination. 




 Removal of the tert-butyl groups from the cyclic urea products could be accomplished 
upon stirring in trifluoroacetic acid at 80 oC for 1 hour (Scheme 1.25). Further deprotection via 
removal of the carbonyl was performed in concentrated HCl at reflux for 24 hours (Scheme 
1.25). The free diamine was obtained in high yield and optical purity. 
 
Scheme 1.25 
 The asymmetric diamination via C-H bond activation and employing ligand ent-1-26, has 
been applied in the total synthesis of substance P receptor antagonist (+)-CP-99,994 (Scheme 
1.26).61 Diamination of 1,5-hexadiene employing C-H activation diamination conditions and 
ligand 1-26 yielded cyclic urea 1-27 which was employed as a chiral ligand for asymmetric 









Shi and coworkers have also reported the diamination of conjugated dienes using N-heterocyclic 
carbene-Pd(0) complexes as catalysts.63 Recently, Pd(PPh3)4 was used as catalyst for sequential 
C-N bond formation via allylic and aromatic C-H amination of α-methylstyrenes.64 Four C-N 




 Shi and coworkers have also developed a Cu-catalyzed diamination process for 
conjugated diene substrates which is complementary in regioselectivity to that of the Pd-
catalyzed processes. Using CuCl-P(OPh)3 as catalyst and 1-17 as nitrogen source, the terminal 
double bond of conjugated dienes were diaminated with high regioselectivity (Figure 1.15).65 
One exception to the high terminal selectivity was the diamination of trans-1,3-pentadiene which  
gave a 1 : 1.3 ratio of terminal to internal products. It was proposed that the reaction proceeded 
through a radical mechanism (Scheme 1.27). The copper catalyst reductively cleaves the N-N 
bond of the diaziridinone to give radical species 1-28. Terminal addition of 1-28 into the diene 
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yields π-allyl radical species 1-29 which upon radical recombination, or formation of Cu(III) 
species 1-30 and successive reductive elimination, gives the diamination product and recycles 







 Due to the proposed radical pathway, an asymmetric variant proved to be challenging 
however enantioselectivities for terminal diamination could be obtained using ligand 1-31 or 
copper catalysts with chiral counteranions (1-32) (Figure 1.16). Diamination using (R)-DTBM-
SEGPHOS (1-31) provided encouraging ee’s ranging from 23-74% for a variety of conjugated 
dienes and a triene.66 Chiral copper catalyst 1-32 also effectively induced asymmetry with 49-
61% ee for conjugated dienes and a triene.67  
 
Figure 1.16 
 1,1-Disubstituted terminal olefins were also found to be good substrates for Cu(I)-
catalyzed diamination using nitrogen source 1-17. A variety of 1,1-disubstituted olefins 
including substituted α-methylstyrenes were efficiently diaminated in moderate to good yields 
(Figure 1.17) and the method was employed for the synthesis of a potent NK1 antagonist 
(Scheme 1.28).68 Other related methods employing diaziridinone 1-17 include the Cu-catalyzed 
C-H α-amination of esters69 and aryl ketones70 to synthesize hydantoins and imidazolinones 
respectively. An alternative nitrogen source (1-33) has also been reported for the 
cycloguanidination of terminal olefins (Figure 1.18).71 Conjugated dienes, trienes, enynes and 
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2.1 GENERAL INTRODUCTION 
 The β,γ-diamino acid motif is an area of active research because of its prevalence in 
biologically active molecules and its use in peptide library syntheses.1 Statine [(3S,4S)-4-amino-
3-hydroxy-6-methylheptanoic acid, Sta] (2-1) (Figure 2.1) is an integral component of the 
aspartyl proteinase inhibitor pepstatin A. Incorporation of statine into structural analogues has 
led to the discovery of a variety of potent inhibitors of renin, an aspartyl proteinase that plays a 
role in hypertension. One such derivative is 3-aminodeoxystatine (Asta) (2-2) (Figure 2.1).2 
(S,S)-2-2 has displayed similar IC50 values for renin inhibition as (S,S)-2-1 while improved 
potencies of (S,R)-2-2 were noticed compared to (S,R)-2-1.2a Another example of the β,γ-
diamino acid motif is emeriamine (2-3) and the emericedine family of betaines (2-4, 2-5 and 2-
6), which have shown to be effective inhibitors of fatty acid-oxidation (Figure 2.1).3 
 
Figure 2.1 
Cyclization of β,γ-diamino acids gives the closely related 4-aminopyrrolidinones 2-7 (Figure 
2.1). These five-membered amino lactams have been reported to potentiate insulin activity when 
incorporated into hypoglycaemic peptide analogues and make the analogues more stable towards 
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physiological degradation.4 The 4-aminopyrrolidinone motif was also incorporated into the 
CCK-A tetrapeptide, which plays a role in the regulation of food intake in animals. The 
aminopyrrolidinone moiety provided a conformationally constrained environment which 
displayed beneficial agonist activity in vitro.5 4-Aminopyrrolidinones have also been observed in 
biologically active natural products such as the macrocyclic Microsclerodermins6 and 
Koshikamide B7 (Figure 2.2). 
 
Figure 2.2 
2.1.1 Methods to Synthesize β,γ-Diamino Acids and 4-Aminopyrrolidinones 
 Various methods have been reported for the synthesis of β,γ-diamino acids and related 4-
aminopyrrolidinones. Although functionally quite simple, a direct route to synthesize these 
motifs require multi-step procedures and rely heavily on commercially available amino acids as 
starting materials, thus limiting the structural variability for biological studies. The following 
section will highlight the currently available routes to synthesize these compounds. 
 In 1986, Harris and coworkers reported the first synthesis of protected 3-
aminodeoxystatine from (S)-Boc-leucinal (Scheme 2.1).2a,8 Wittig reaction of aldehyde 2-8 and 
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conjugate addition of ammonia gave β,γ-diamino ester 2-10. Protection of the free amine with 
benzyl chloroformate and hydrolysis of the ester furnished a 1:1 mixture of diastereomeric 




 Schostarez synthesized 3-aminodeoxystatine starting from N-Boc-L-Leucine, establishing 
diastereoselectivity and thus eliminating the need for diastereomeric separations (Scheme 2.2).9 
A stereoselective intramolecular Mitsunobu reaction of 2-13 established the desired 
stereochemistry of the amine followed by reductive removal of the amide methoxy to give 2-15. 
Aqueous KOH was used to cleave the amide and yield the suitably protected aminodeoxystatine 




 Kano and coworkers reported the synthesis of diamino acid 2-26 using the aminoalcohol 
derived from D-phenylalanine (Scheme 2.3).10 Methylation of amide 2-17 was accomplished 
using MeLi and reduction of the ketone was accomplished using Et3SiH and TiCl4 in high 
diastereoselectivity. Cyclization of amino alcohol 2-19 using NaOH yielded oxazolidinone 2-20. 
The amide nitrogen was Boc protected and ring opening yielded Boc-protected amino alcohol 2-
22. Replacement of the alcohol with azide was performed using methanesulfonyl chloride and 
cleavage of the phenyl group was accomplished using ruthenium chloride-sodium metaperiodate 
to give 2-25. Catalytic hydrogenation of azide 2-25 over Pd black yielded Boc-protected 




 In 2005, Kim and coworkers reported an intramolecular conjugate addition of carbamate 
to α,β-unsaturated esters as a viable route to synthesize 3-aminodeoxystatine derivatives 
(Scheme 2.4).11 Starting from N-Boc-L-Leucine, benzyl carbamate was used to give the 
unsaturated ester containing a methylamido group (2-28). Treatment with NaH induced 
conjugate addition to the ester and catalytic oxidation using RuCl3 yielded the diamine ester of 3-




 In 2009, Concellón and coworkers reported the addition of samarium enolates, derived 
from esters and amides, to imines to yield β,γ-diamino esters and amides (Scheme 2.5).12 Imines 
2-31 were synthesized from protected amino acids and the enantiopure 3,4-diamno esters (2-32) 
were obtained in moderate yields upon treatment with samarium. Deprotection of the sulfoxide 
group was accomplished using HCl.  
 
Scheme 2.5 
 Conjugate addition of lithium amides to α,β-unsaturated esters has shown to be a direct 
route to diamino acids13 and a stereoselective synthesis via kinetic resolution has also been used 
for the synthesis of diamino acids and 4-aminopyrrolidinones. Davies and coworkers used chiral 
lithium amides for the kinetic resolution of racemic γ-amino-α,β-unsaturated esters (2-33), giving 
good yields and excellent diastereoselectivities (Scheme 2.6).14 The resulting diamines were 









 Misiti and coworkers employed a Curtius rearrangement in their synthesis of both 
enantiomers of emeriamine from commercially available N-Cbz-L-aspartic acid 4-tert-butyl ester 
(Scheme 2.8).15 Phthalimido protection (2-40) of the amine was necessary to avoid 
imidazolidinone formation during the Curtius rearrangement. Selective conversion of the t-butyl 
ester to the carboxylic acid 2-41 and subsequent Curtius rearrangement followed by quenching 
with benzyl alcohol yielded diamino ester 2-42 in good yield. Removal of Cbz and subsequent 
methylation proceeded smoothly to give protected (R)-emeramine (2-44) in 22% overall yield 
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over 10 steps. Additional syntheses of emeriamine have been reported from (R)-carnitine through 
double inversion of configuration16 and also from D-aspartic acid.17 
 
Scheme 2.8 
 Kouklovsky, Alezra and coworkers have utilized a tandem zinc-mediated 
homologation/Blaise reaction to synthesize 4-aminopyrrolidinones (Scheme 2.9) and β,γ-diamino 
acids (Scheme 2.10) from readily available α-amino acids.18 Starting from L-leucine, Cbz 
protection and conversion of the acid to the amide furnished 2-46. Dehydration of the amide to 
nitrile 2-47 finished the 3 step sequence in 43% yield.18a A second protection of the amine was 
necessary for the following Blaise reaction to proceed which yielded the cyclic urea 2-50 in 81% 
yield. Reduction using NaBH3CN gave the diastereomer shown as the major product (2-51). 
Addition of acid and elevated temperature gave the 4-aminopyrrolidinone hydrochloride salt 2-
52. Further protecting group manipulations and opening of the five-membered ring with LiOH 







 Jayaraman, Bhawal and coworkers used β-lactams as key intermediates for the synthesis 
of aminopyrrolidinones (Scheme 2.11).19,20 Acetonide formation of amino alcohol 2-56 and 
subsequent Boc protection yielded primary alcohol 2-57 in 70% yield. Swern oxidation and 
imine formation gave the cycloaddition precursors 2-59. In the presence of triethylamine, 
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cyclization occured and provided β-lactams 2-60 in 73-94% yield. Treatment of these β-lactams 




 In 2011, Sá and coworkers reported the nucleophilic ring-opening of aziridines for the 
racemic synthesis of aminopyrrolidinones (Scheme 2.12).21 Epoxidation of 2-62 followed by ring 
opening with lithium bromide set the required stereochemistry for displacement with azide (2-
64). Aziridine formation is accomplished using triphenylphosphine and the second nitrogen is 
added as azide to give the β,γ-diamino ester 2-67. Reduction of the azide and concomitant 
cyclization gave the aminopyrrolidinone 2-68. Additional proceedures for the synthesis of 
aminopyrrolidinones include the derivatization of natural asparagine,22 radical addition-




 The methods presented above illustrate the currently available routes to β,γ-diamino acids 
and 4-aminopyrrolidinones. Although the core of these functional motifs is structurally simple, 
high step counts, low yields, and substrate scope limitations plague the abovementioned routes. It 
was envisioned that these motifs could be readily synthesized via the diamination protocols 
developed in our lab in a direct and efficient manner. This chapter will describe the preliminary 
results on the synthesis of both β,γ-diamino acids and 4-aminopyrrolidinones. 
2.2 RESULTS and DISCUSSION 
2.2.1 Retrosynthetic Analysis 
 It was proposed that the common limitations in current routes could be greatly minimized 
by using the diamination method developed in our group and a retrosynthetic plan was 
formulated to access these compounds in five to six steps from simple terminal olefins or 
conjugated dienes (Scheme 2.13). Employing Pd-catalyzed diamination of readily available 
terminal olefins or dienes (2-69) installs both nitrogen moieties in one step followed by anti-
Markovnikov hydration of the terminal double bond (2-71). Oxidation of the alcohol to the 
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carboxylic acid would give 2-72. Deprotection would yield β,γ-diamino acids 2-73, which could 
then be cyclized to yield corresponding 4-aminopyrrolidinones 2-74. Because the diamination of 
2-69 can be carried out in an asymmetric fashion, this route is also amenable for the chiral 




 Diamination product 2-75a was chosen for screening with racemic material, and the 
hydroboration and oxidation of the terminal double bond was pursued (Scheme 2.14). It was 
found that steric hindrance between the hydroborating reagent and the nitrogen tert-butyl groups 
of the substrate played a factor in the selectivity of the hydroboration. Smaller reagents resulted 
in a mixture of regioisomers (Table 2.1, entries 1-3, 6), whereas the bulky 9-BBN (Table 2.1, 
entry 5) gave no reaction. Cy2BH (Table 2.1, entry 4) provided the highest selectivity for the 




Table 2.1 Screening Conditions for Hydroboration and Oxidation of Cyclic Ureas 
Entry Reagent 2-76a : 2-76ba Yield (%) 
1 BH3-THF 1.3 : 1 36 
2 BH3-SMe2 1 : 1.2 34 
3 BH2Cl-SMe2 2.8 : 1 66 
4 Cy2BH 1 : 0 70 
5 9-BBN NR - 
6 
 
1.2 : 1 58 
7 
 
1 : 0 35 
a Selectivity determined by crude 1H NMR 
Optimization of the reaction conditions started with the in-situ formation of Cy2BH. It 
was found that 1.5 eq of 1M BH3-THF to 3 eq cyclohexene formed this intermediate, by 
monitoring the disappearance of stating material by TLC. Reaction conditions including solvent, 
NaOH loading and reaction time were screened and the optimal conditions are presented in Table 





Table 2.2 Hydroboration of Cyclic Ureasa 






















5b 2-75e 2-76e 58 
a All reactions were carried out with 2-75 (0.1 mmol), Cy2BH (0.15 mmol), 2.5 M NaOH (0.3 
mmol), 30% H2O2 (1.63 mmol) in THF at 0 oC for 9.5 h unless otherwise stated. Reactions were 






2.2.3 Oxidation to Carboxylic Acid 
 Methods for the direct oxidation of the alcohol to the carboxylic acid were subsequently 
screened (Scheme 2.15). Each reaction resulted in almost complete disappearance of starting 
material and similar isolated yield (Table 2.3), however purification of the resulting acid proved 
to be the deciding factor. Whereas the other methods required column purification or resulted in 
generation of hazardous waste, the TEMPO-catalyzed NaOCl oxidation (Table 2.3, entry 5) 
provided the acid in sufficiently pure form after acidification and extraction from the reaction 
mixture, and no further purification was required. After the screening of the compounds shown 
in Table 2.4, entries 3 and 4 showed interesting reactivity. As determined by crude 1H NMR, 
entry 3 was determined to be a mixture of products. The major product was the desired acid and 
minor product was thought to be a product of possible chlorination, however this was neither 
isolated nor characterized. It was determined by crude 1H NMR that the double bond in entry 4 







Table 2.3 Screening Conditions for Oxidation to Acid 
Entry Oxidation System Conversion (%)a Yield of 2-77a (%) 
1 RuCl3, NaIO4 >90% 56 
2 KMnO4 100 50 
3 PtO2, O2 >90% - 
4 PDC 100 60 
5 TEMPO, NaOCl 100 65 
a Conversion determined by crude 1H NMR 
Table 2.4 Oxidation of Cyclic Diamino Alcoholsa 




















4 2-77d B 60 
a Method A: Reactions were carried out with 2-76 (0.23 mmol), TEMPO (2.3 x10-3 mmol), 
NaHCO3/KBr/TBACl soln. (0.44 mL), NaOCl/NaHCO3/NaCl (7.2 mmol) in DCM at 0 oC for 18 
h unless otherwise stated. For entry 1, reaction was run on 1.2 scale. Method B: Reactions were 
carried out with 2-76 (0.06 mmol), PDC (0.207 mmol) in DMF at rt unless otherwise stated. For 




 With the hydroboration and oxidation steps optimized, it was envisioned that 
deprotection of the t-butyl groups on the nitrogens followed by decarbonylation would yield the 
β,γ-diamino acid derivatives. Removal of the t-butyl groups proved to be facile as has been 
previously reported by heating at 80 oC for 2.5 hours in CF3CO2H. Isolation of the β,γ-diamino 
acid proved to be much more difficult and presented additional challenges. After refluxing in 2M 
HCl for 2 hours, it was found that acid-catalyzed cyclization was occurring rapidly, resulting in 
lactamization to give the corresponding 4-aminopyrrolidinones 2-79 (Scheme 2.16). After 
optimization of acid concentration, reaction time and temperature, lactamization using 2M HCl 
at 150 oC for 14 h and subsequent basification with NaOH provided the 4-aminopyrrolidinones 









Table 2.5 Lactamization of Carboxylic Acidsa 












3 2-79c 70 
a All reactions were carried out with 2-77 (0.5 mmol), CF3CO2H at 80 oC for 3 h, then 2N HCl at 
150 oC for 14 h. 
   
 It was then of interest to intercept the possible β,γ-diamino acid intermediate before 
cyclization and it was envisioned that this could be accomplished with milder reaction 
conditions. However, all efforts via lower temperatures and more dilute acid concentrations 
failed to stop the cyclization from occurring and mixtures of starting material and lactam were 
obtained. 
 Alternate routes were then explored in attempts to isolate the β,γ-diamino acid 
derivatives. Following diamination of 4-phenyl-1-butene, the tert-butyl groups of 2-75a were 
removed by stirring in CF3CO2H at 80oC for 2 hours (Scheme 2.17). Decarbonylation was then 
executed using conc. HCl at reflux for 24 hours. After basification and extraction, 2-80 was 
obtained in 66% yield over three steps from 4-phenyl-1-butene. The hydroboration of 2-80 was 
then attempted using the conditions described above (Table 2.2). This was unsuccessful 
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however, most likely due to the basic nature of the free amine groups which deactivated the 




 The efficient and enantioselective synthesis of the β,γ-diamino acid motif still warrants 
further investigation as it is a useful functional group present in biologically active molecules and 
serves as a precursor to β- and γ-peptides. It appears that through the current route, these 
compounds are difficult to isolate. Current procedures to synthesize 4-aminopyrrolidinones 
require multiple steps, often necessitate protecting group manipulation, and substitution at the 5-
position is often limited to alkyl groups originating from natural amino acids. Utilizing the above 
described method, various substituted 4-aminopyrrolidinones can be synthesized over five steps 
from readily available dienes or terminal olefins in up to 40% overall yield, providing a 
competitive process in the synthesis of these compounds. One can also envision that reduction of 
the 4-aminopyrrolidinone compounds to the corresponding 3-aminopyrrolidines would be of 
worth, as pyrrolidines are present in numerous natural products and have a wide applicability in 





Representative Diamination of Terminal Olefins (2-75a).25 A 1.5-mL vial charged with 
Pd(PPh3)4 (0.0924 g, 0.08 mmol) was evacuated and then filled with argon followed by addition 
of 4-phenyl-1-butene (0.211 g, 1.6 mmol). The resulting mixture was immersed into an oil bath 
(65 °C) with stirring. Di-t-butyldiaziridinone (1-17) (0.748 g, 4.4 mmol) was added by syringe 
pump at the rate of 0.4 mmol/h. Upon completion of addition (7 h), the reaction mixture was 
stirred for another hour and purified by flash chromatography (silica gel, hexane:ethyl acetate = 
4:1) to give the product 2-75a as a colorless oil (0.432 g, 90% yield).  
Representative Diamination of Conjugated Dienes (2-75d).26 A 1.5-mL vial charged with 
Pd(PPh3)4 (0.023 g, 0.02 mmol) was evacuated and then filled with argon followed by addition 
of (3E,5E)-undeca-1,3,5-triene (0.036 g, 0.24 mmol) and benzene-d6 (0.6 mL). Di-t-
butyldiaziridinone (1-17) (0.034 g, 0.2 mmol) was added and the resulting mixture was 
immersed into an oil bath (65 °C) with stirring for 30 min. The reaction mixture was purified by 
flash chromatography (silica gel, hexane:ethyl acetate = 4:1) to give the product 2-75d as a 
yellow oil (0.062 g, 81% yield).  
Representative Hydroboration of Cyclic Ureas (Table 2.2, entry 2). A 3 mL vial charged 
with a magnetic stir bar and 1M BH3-THF (0.15 mL, 0.15 mmol) was cooled to 0 oC followed by 
addition of cyclohexene (0.03 mL, 0.3 mmol) and stirred for 2.5 h. 1,3-di-tert-butyl-4-hexyl-5-
vinylimidazolidin-2-one (2-75b) (31 mg, 0.1 mmol) in THF (0.1 mL) was added slowly and the 
mixture was allowed to stir at rt for 5 h. Upon completion of the reaction via monitoring by TLC, 
the reaction was cooled to 0 oC and 2.5M NaOH (0.12 mL, 0.3 mmol) was added followed by 
30% H2O2 (0.05 mL, 1.63 mmol). The reaction was stirred for 30 min, whereupon it was diluted 
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with EtOAc and the aqueous layer was separated from the organic layer. The organic layer was 
washed with H2O and brine (3 times), dried over Na2SO4 and concentrated. The residue was 
purified by flash chromatography [silica gel; Hex, then Hexanes:EtOAc 1:15 (50 mL), then 
Hexanes:EtOAc 1:4] to give the cyclic diamino alcohol 2-76b as a white solid (30mg, 92% 
yield). 
Representative TEMPO Oxidation of Cyclic Diamino Alcohols, Method A (Table 2.4, entry 
1). To a 3 mL vial equipped with a magnetic stir bar charged with 1,3-di-tert-butyl-4-(2-
hydroxyethyl)-5-phenylimidazolidin-2-one (2-76a) (74 mg, 0.23 mmol) in DCM (0.66 mL) was 
added TEMPO (0.35 mg, 2.3x10-3 mmol) and a solution of sat NaHCO3/KBr/TBACl (0.44 
mL/0.02mmol/0.01mmol). The reaction was cooled to 0 oC followed by addition of a solution of 
NaOCl/sat NaHCO3/sat NaCl (7.2 mmol/0.24 mL/0.47 mL) over 35 min. The reaction was 
allowed to warm to rt and stir overnight. The mixture was diluted with DCM and the aqueous 
layer was separated from the organic layer. The organic layer was washed with H2O (3 times), 
dried over MgSO4 and concentrated. The white carboxylic acid solid (2-77a) was pure by 1H 
NMR and used directly without further purification (58.4 mg, 76%). 
Representative PDC Oxidation of Cyclic Diamino Alcohols, Method B (Table 2.4, entry 3). 
To a 3 mL vial equipped with a magnetic stir bar was added 1,3-di-tert-butyl-4-(2-hydroxyethyl)-
5-(4-methoxyphenyl)imidazolidin-2-one (2-76c) (50 mg, 0.14 mmol) and PDC (189 mg, 0.5 
mmol) in DMF (0.75 mL). The reaction was stirred at room temperature overnight. The reaction 
was diluted with H2O and extracted with Et2O eight times. The combined organic layers were 
washed with H2O (3 times), dried over MgSO4 and concentrated. The residue was purified by 
flash chromatography [silica gel; Hexanes:EtOAc 6:1 1% AcOH] to give the white carboxylic 
acid solid 2-77c  (74 mg, 60% yield). 
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Representative Lactamization (Table 2.5, entry 3). To a 3 mL vial equipped with a magnetic 
stir bar was added 2-(1,3-di-tert-butyl-5-(4-methoxyphenyl)-2-oxoimidazolidin-4-yl)acetic acid 
(2-77c) (20 mg, 0.05 mmol) and CF3CO2H (0.7 mL) and stirred at 80 oC for 3 h. Upon 
concentration, the residue was transferred to a high-pressure vessel and dissolved in 2M HCl (0.5 
mL). The reaction was then heated in a sand bath measuring 150 oC and stirred for 14 h after 
which the vessel was allowed to cool and the water was removed under reduced pressure. The 
resulting residue was dried under reduced pressure at 150 oC for 3h after which the sample was 
dissolved in water and made basic using 2.5 M NaOH (pH~14).  The product was extracted using 
CHCl3 and washed with H2O (3 times), brine, dried over Na2SO4 and concentrated to give 4-
aminopyrrolidinone 2-79c as a dark yellow oil (7.8 mg, 70%) 
 Table 2.2, entry 1 (rc_b2_40), (rc_b2_44). 
 
White solid; mp 144 oC; IR (film) 3422, 2961, 1660 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.36-
7.20 (m, 5H), 4.40 (s, 1H), 3.87 (t, J = 6.3 Hz, 2H), 3.36 (dd, J = 7.5, 3.6 Hz, 1H), 2.42 (brs, 1H), 
2.20-1.82 (m, 2H), 1.36 (s, 9H), 1.29 (s, 9H); 13C NMR (75 MHz, CDCl3) δ 159.0, 144.3, 128.9, 
127.7, 125.8, 61.6, 60.0, 59.1, 53.5, 52.9, 38.1, 29.1; HRMS Calcd for C19H30N2O2 (M+H)+: 




Table 2.2, entry 2 (rc_b3_5_1), (rc_b3_38_4). 
 
White solid; mp 62 oC; IR (film) 3422, 2958, 2929, 2858, 1660 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 3.79-3.60 (m, 2H), 3.38 (dd, J = 8.1, 3.6 Hz, 1H), 3.22 (dd, J = 8.1, 3.6 Hz, 1H), 1.95 
(brs, 1H), 1.84-1.72 (m, 2H), 1.54-1.42 (m, 2H), 1.38 (s, 9H), 1.37 (s, 9H), 1.34-1.16 (m, 8H), 
0.88 (t, J = 6.3 Hz, 3H); 13C NMR (75 MHz, CDCl3) δ 158.2, 58.9, 58.0, 55.0, 52.6, 52.5, 37.2, 
34.3, 31.9, 29.5, 29.2, 24.8, 22.7, 14.2; HRMS Calcd for C19H38N2O2 (M+H)+: 327.3006, Found: 
327.3005. 
 Table 2.2, entry 3 (rc_b2_47_1), (rc_b3_43_1). 
 
White solid; mp 104-109 oC; IR (film) 3417, 2960, 1660 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.20 (d, J = 9.0 Hz, 2H), 6.86 (d, J = 9.0 Hz, 2H), 4.34 (s, 1H), 3.88 (t, J = 6.3 Hz, 2H), 3.81 (s, 
3H), 3.35 (dd, J = 6.9, 3.9 Hz, 1H), 1.98-1.85 (m, 2H), 1.38 (s, 9H), 1.29 (s, 9H); 13C NMR (75 
MHz, CDCl3) δ 159.2, 159.0, 136.6, 127.0, 114.2, 61.2, 60.1, 59.3, 55.4, 53.5, 53.0, 38.1, 29.11, 
29.08; HRMS Calcd for C20H32N2O3 (M+H)+: 349.2486, Found: 349.2494. 
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Table 2.2, entry 4 (rc_b2_47_2), (rc_b3_43_3). 
 
Colorless oil; IR (film) 3422, 2959, 2926, 2871, 1660 cm-1; 1H NMR (300 MHz, CDCl3) δ 5.65-
5.40 (m, 2H), 3.79-3.66 (m, 3H), 3.30 (dd, J = 6.9, 3.6 Hz, 1H), 2.34 (brs, 1H), 2.06-1.94 (m, 
2H), 1.89-1.76 (m, 2H), 1.37 (s, 9H), 1.33 (s, 9H), 1.42-1.18 (m, 6H), 0.87 (t, J = 6.6 Hz, 3H); 
13C NMR (75 MHz, CDCl3) δ 158.6, 132.3, 131.5, 60.8, 59.1, 57.6, 53.2, 53.0, 37.0, 32.2, 31.5, 
29.1, 28.9, 22.6, 14.2; HRMS Calcd for C20H38N2O2 (M+H)+: 339.3006, Found: 339.3013. 
Table 2.2, entry 5 (rc_b3_13_1). 
 
Colorless solid; mp 96-100 oC; IR (film) 3425, 2960, 1656 cm-1; 1H NMR (300 MHz, CDCl3) δ 
3.73 (t, J = 6.9 Hz, 2H), 3.55 (t, J = 6.6 Hz, 1H), 2.27-2.13 (m, 1H), 2.12-1.96 (m, 3H), 1.88-
1.77 (m, 1H), 1.76-1.63 (m, 2H), 1.60-1.44 (m, 1H), 1.47 (s, 9H), 1.37 (s, 9H); 13C NMR (100 
MHz, CDCl3) δ 158.5, 67.8, 64.2, 59.3, 54.8, 53.1, 44.1, 42.2, 37.0, 30.0, 29.0, 23.5; HRMS 




Table 2.4, entry 1 (rc_b2_27_2), (rc_b2_42), (rc_b3_46_1). 
 
White solid; mp 203-206 oC; IR (film) 2964, 1723, 1626 cm-1; 1H NMR (300 MHz, CDCl3) δ 
7.41-7.28 (m, 5H), 4.45 (s, 1H), 3.65 (dd, J = 7.2, 1H), 2.82-2.64 (m, 2H), 1.38 (s, 9H), 1.32 (s, 
9H); 13C NMR (75 MHz, CDCl3) δ 175.5, 158.6, 143.0, 128.9, 128.0, 126.1, 61.8, 58.6, 53.7, 
53.1, 39.8, 29.10, 29.06; HRMS Calcd for C19H28N2O3 (M+H)+: 333.2173, Found: 333.2178. 
 
Table 2.4, entry 2 (rc_b3_14_1), (rc_b3_46_2). 
 
Yellow oil; IR (film) 2959, 2929, 2858, 1733, 1653 cm-1; 1H NMR (300 MHz, CDCl3) δ 3.66 
(dd, J = 7.8, 5.4 Hz, 1H), 3.27 (t, J = 6.0 Hz, 1H), 2.63-2.52 (m, 2H), 1.58-1.45 (m, 2H), 1.39 (s, 
9H), 1.38 (s, 9H), 1.46-1.23 (m, 8H), 0.89 (t, J = 5.7 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 
171.4, 157.7, 60.6, 58.6, 52.8, 52.7, 33.8, 32.0, 29.5, 29.3, 29.2, 24.7, 22.8, 21.3, 14.4; HRMS 





Table 2.4, entry 3 (rc_b4_19). 
 
White solid; mp 197-200 oC; IR (film) 2973, 1613, 1512 cm-1; 1H NMR (300 MHz, CDCl3) δ 
11.15 (bs, 1H), 7.24 (d, J = 8.4 Hz, 2H), 6.86 (d, J = 8.4 Hz, 2H), 4.40 (s, 1H), 3.79 (s, 3H), 3.63 
(dd, J = 8.1, 4.2 Hz, 1H), 2.78-2.63 (m, 2H), 1.37 (s, 9H), 1.30 (s, 9H); 13C NMR (75 MHz, 
CDCl3) δ 175.3, 159.3, 158.6, 135.1, 127.2, 114.1, 61.3, 58.8, 55.4, 53.6, 53.0, 39.7, 29.1, 29.0; 
HRMS Calcd for C20H30N2O4 (M+H)+: 363.2278, Found: 363.2283. 
 
Table 2.4, entry 4 (rc_b3_48). 
 
White solid; mp 72 oC; IR (film) 2960, 2927, 2872, 1733, 1692, 1653 cm-1; 1H NMR (300 MHz, 
CDCl3) δ 5.73-5.58 (m, 1H), 5.57-5.44 (m, 1H), 3.78 (d, J = 7.5 Hz, 1H), 3.58 (dd, J = 9.0, 3.6 
Hz, 1H), 2.72-2.52 (m, 2H), 2.10-1.98 (m, 2H), 1.39 (s, 9H), 1.35 (s, 9H), 1.46-1.22 (m, 6H), 
0.89 (t, J = 6.6 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 175.8, 158.1, 133.2, 130.5, 60.8, 56.7, 
53.3, 53.0, 38.4, 32.3, 31.5, 29.2, 28.9, 22.7, 14.3; HRMS Calcd for C20H36N2O3 (M+H)+: 
353.2799, Found: 353.2805. 
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Table 2.5, entry 1 (rc_b4_16). 
 
Dark green oil; IR (film) 3263, 2922, 2850, 1691 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.46-7.31 
(m, 3H), 7.30-7.23 (m, 2H), 6.27 (brs, 1H), 4.84 (d, J = 6.0 Hz, 1H), 3.95-9.85 (m, 1H), 2.72 (dd, 
J = 16.8 ,7.5 Hz, 1H), 2.25 (dd, J = 16.8, 5.4 Hz, 1H); 13C NMR (100 MHz, CDCl3) δ 177.1, 
136.9, 129.1, 128.6, 127.1, 63.2, 52.2, 39.6; HRMS Calcd for C10H12N2O (M+H)+: 177.1022, 
Found: 177.1018. 
 
Table 2.5, entry 2 (rc_b4_31_2). 
 
Yellow oil; IR (film) 3211, 2927, 2856, 1695 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.05 (brs, 1H), 
3.72-3.63 (m, 1H), 3.61-3.52 (m, 1H), 2.61 (dd, J = 16.4, 7.2 Hz, 1H), 2.12 (dd, J = 16.4, 4.4 Hz, 
1H), 1.66-1.54 (m, 1H), 1.54-1.42 (m, 1H), 1.41-1.14 (m, 8H), 0.90 (t, J = 6.4 Hz, 3H); 13C 
NMR (100 MHz, CDCl3) δ 176.5, 59.0, 50.6, 40.9, 31.9, 29.49, 29.46, 26.5, 22.8, 14.2; HRMS 




Table 2.5, entry 3 (rc_b4_31_1). 
 
Orange oil; IR (film) 3264, 2921, 2850, 1691, 1247 cm-1; 1H NMR (300 MHz, CDCl3) δ 7.19 (d, 
J = 8.4 Hz, 2H), 6.94 (d, J = 8.4 Hz, 1H), 6.03 (brs, 1H), 4.79 (d, J = 6.3 Hz, 1H), 3.92-3.78 (m, 
1H), 3.83 (s, 3H), 2.70 (dd, J = 17.1, 7.5 Hz, 1H), 2.24 (dd, J = 17.1, 5.7 Hz, 1H); 13C NMR (100 
MHz, CDCl3) δ 176.9, 159.9, 128.7, 128.3, 114.5, 62.7, 55.6, 52.1, 39.6; HRMS Calcd for 
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3.1 GENERAL INTRODUCTION 
3.1.1 Regioselective Diamination Using Diaziridinone 
 As part of the ongoing efforts in our lab to study the mechanism of metal-catalyzed 
diaminations using diaziridinone as nitrogen source, the study of the terminal diamination 
mechanism was further investigated. It was initially reported that a mixture of diamination 
products was observed when (E)-penta-1,3-diene was subjected to the reaction conditions 
(Scheme 3.1).1  
 
Scheme 3.1 
Upon closer inspection, it was found that reaction conditions played a very influential role in the 
observed selectivity of diamination. Varying reaction conditions such as Cu(I) salt, addition of 
ligand, temperature and concentration, the regioselectivity of diamination could be tuned to favor 
internal diamination (Scheme 3.2).2 The reaction proved to be very efficient and a wide variety 
of substitution on the dienes could be tolerated (Figure 3.1). The use of CuBr instead of Pd(0) 
provided an economical alternative to synthesize the internal regioisomer and the reaction could 







3.1.2 Alternative Nitrogen Source and Interesting Reactivity 
 Additionally, alternative nitrogen sources have been reported to be effective nitrogen 
transfer reagents. In 2007, Shi and coworkers reported N,N-di-tert-butylthiadiaziridine 1,1-
dioxide (3-1) as nitrogen source for the diamination of terminal olefins (Figure 3.2).3 Using CuCl 
as catalyst with P(n-Bu)3 as ligand, various substituted styrenes, terminal olefins and an enyne 
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were diaminated in good yields. The sulfone moiety could also be removed to provide free 
diamines using HCl/BaCO3. The nitrogen source, N,N-di-tert-butylthiadiaziridine 1,1-dioxide (3-






 It was also found that nitrogen source 3-1 exhibited interesting reactivity when applied to 
the diamination of terminal olefins. Whereas Pd-catalyzed diamination of terminal olefins using 
diaziridinone 1-17 resulted in diamination at the allylic and homoallylic carbons via a C-H 
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activation mechanism, employing thiadiaziridine 3-1 resulted in an overall dehydrogenative 
diamination (Scheme 3.4).5 A variety of terminal olefins with aryl and alkyl substitution as well 






 The unexpected dehydrogenative diamination is proposed to proceed via the mechanism 
shown in Scheme 3.5. The palladium catalyst inserts into the N-N bond of thiadiaziridine 3-1 to 
form four-membered Pd complex 3-2 which coordinates to the terminal olefin to give complex 3-
3. Upon removal of an allylic hydrogen, (π-allyl)Pd complex 3-4 provides allylic sulfamide 3-5 
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via reductive elimination and regenerates the Pd(0) catalyst. Coordination of another equivalent 
of four-membered complex 3-2 undergoes Pd(II)-catalyzed cyclization to give 3-7. β-Hydride 




 The above methods to install vicinal diamine functionality using thiadiaziridine 3-1 allow 
facile introduction of nitrogen into readily available starting materials. Also of importance are 
the resulting cyclic sulfamide motifs themselves. Cyclic sulfamides are promising functional 
moieties present in many medicinal and biologically active molecules6 and have also been used 
as chiral control agents.7 The interesting diamination reactivity observed with Cu(I) salts as 
catalysts and 1-17 (Scheme 3.2), prompted us to study the possible unique reactivity using 
nitrogen source 3-1 and to develop a concise route to the synthetically valuable cyclic sulfamide 
motif from readily available conjugated dienes. The following chapter describes our studies on 
the Cu(I)-catalyzed regioselective diamination of conjugated dienes to form cyclic sulfamides.  
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3.2 RESULTS AND DISCUSSION 
3.2.1 Reaction Conditions and Substrate Scope 
 Investigation began using (E)-nona-1,3-diene as test substrate and studying the effect of 
reaction conditions. As shown in Table 3.1, both regioisomers can be formed and the 
regioselectivity can be heavily influenced by the reactions parameters. After screening various 
Cu(I) and Cu(II) salts as catalysts, CuCl and CuBr were found to give the best reactivity (Table 
3.1, entries 6 and 7). CuCl displayed a slight preference for the internal diamination 3-10a, 
whereas CuBr gave a much higher preference for internal product 3-10a. Addition of ligand 
proved to be a major factor influencing regioselectivity. CuCl with added phosphine ligand 
improved the reactivity as well as regioselectivity and shifted the ratio in favor of terminal 
product 3-9a (Table 3.1, entries 1-5). Both P(Cy)3 and P(n-Bu)3 were found to effectively 
promote terminal diamination (Table 3.1, entries 1 and 2). Likewise, addition of phosphine 
ligand to CuBr also reversed regioselectivity from internal product 3-10a to terminal 3-9a, but 
lowered the reactivity of the catalyst (Table 3.1, entry 9). Concentration also proved to be an 
integral parameter for high regioselectivity. Reactivity as well as terminal regioselectivity was 
further favored using CuCl-P(n-Bu)3 when a more concentrated reaction mixture was used 
(Table 3.1, entry 3). Conversely, internal regioselectivity was further increased using CuBr 






Table 3.1 Effect of Reaction Conditions on Regioselectivity  
of Cu(I)-Catalyzed Diamination of Dienes.a 
 
Entry Conditions Conv (%) 3-9a:3-10a 
1 CuCl-P(Cy)3  (1:1) 44 14:1d 
2 CuCl-P(n-Bu)3 (1:1) 47 14:1d 
3b CuCl-P(n-Bu)3 (1:1)  65 >25:1d 
4 CuCl-P(PPh)3 (1:1) 40 1:1e 
5 CuCl-dppe (1:1) 23 2:1e 
6 CuCl 39 1:3e 
7 CuBr 70 1:10d 
8c CuBr  76 1:19d 
9 CuBr-P(n-Bu)3  (1:1) 24 1.7:1e 
a All reactions were carried out with olefin 3-8a (0.20 mmol), 3-1 (0.24 mmol), and Cu(I) 
catalyst (0.020 mmol) in CDCl3 (0.3 mL) under Ar at rt for 14 h unless otherwise stated.  b 0.1 
mL of CDCl3 was used.  c 0.6 mL of CDCl3 was used.  d When the selectivity is high, an accurate 
ratio of 3-9a to 3-10a was difficult to obtain by 1H NMR analysis of the crude reaction mixture 
due to baseline noise interference.  The ratio was then obtained by 1H NMR analysis after flash 
chromatography (3-9a and 3-10a were nearly inseperable).  e When the selectivity is low, the 
ratio of 3-9a to 3-10a was determined by 1H NMR analysis of the crude reaction mixture. 
 
 With optimal reaction conditions in hand, investigation into the substrate scope for both 
terminal and internal diamination was pursued.8 CuCl/P(n-Bu)3-catalyzed terminal diamination 
was effective for a variety of conjugated dienes and trienes in good to high yield (Table 3.2).  
Electron-rich (Table 3.2, entries 4 and 6) and electron-deficient dienes (Table 3.2, entries 5 and 




Table 3.2 CuCl-catalyzed Regioselective Diaminationa 






3-8a, R = C5H11 












3-8c, Ar = Ph 
3-8d, Ar = p-MeOC6H4 
3-8e, Ar = p-NO2C6H4 



















3-8h, R = Ph 










3-8j, R = Me 





a All reactions were carried out with olefin 3-8 (0.40 mmol), CuCl/P(n-Bu)3 (1:1) complex 
(0.020 mmol), and 3-1 (0.48 mmol) in CDCl3 (0.1 mL) under Ar at rt unless otherwise stated.  
Reaction times: For entry 1, 24 h; entry 2, 48 h; entry 3, 3.5 h; entry 4, 8 h; entry 5, 12 h; entry 6, 
20 h; entry 7, 48 h; entry 8, 12 h; entry 9, 24 h; entry 10, 36 h; entry 11, 8h.  b Olefin 3-8a (0.20 
mmol), CuCl/P(n-Bu)3 (1:1) complex (0.040 mmol), and 3-1 (0.24 mmol).  c CuCl/P(n-Bu)3 (1:1) 
complex (0.080 mmol), and 3-1 (0.80 mmol).  d CuCl/P(n-Bu)3 (1:1) complex (0.080 mmol), and 
3-1 (0.60 mmol).  e CuCl/P(n-Bu)3 (1:1) complex (0.040 mmol), and 3-1 (0.60 mmol).   f 3-1 (0.6 




Although akyl dienes (Table 3.2, entries 1-2) were efficiently diaminated, aryl dienes and trienes 
(Table 3.2, entries 3-6, 8, 10, 11) proved superior and catalyst loading could be reduced to 5 
mol%. All reactions were highly regioselective for terminal diamination and no internal 
regioisomer was detectable by 1H NMR. 
 CuBr-catalyzed internal diamination was examined next. Various trans alkyl dienes were 
readily diaminated at the internal double bond with only one regioisomer being present most of 
the time as judged by 1H NMR (Table 3.3). 1-Monosubstituted (Table 3, entries 1, 2), 1,2- (Table 
3, entry 3), and 1,3-disubstituted (Table 3, entries 4-7), and 1,2,3-trisubstituted (Table 3, entry 8) 
dienes were smoothly diaminated with high regioselectivity and in good yield. Danishefsky’s 
diene was subjected to CuBr conditions to give internal diamination followed by desilylation 
upon purification with silica gel to yield ketone 3-10p (Table 3.3, entry 7). When cis-pentadiene 
was subjected to CuBr-catalyzed conditions, no diamination product was obtained and starting 
material was returned. The internal diamination can also be carried out on gram scale (Table 3.3, 
entry 1). Removal of the tert-butyl groups from the resulting internal cyclic sulfamides can be 
accomplished by stirring in a mixture of CF3CO2H-hexanes (1:1) at room temperature for 7 








Table 3.3 CuBr-Catalyzed Regioselective Diaminationa 







3-8a, R = C5H11 
 







    
  
 










3-8n, R = TMS 












8b 3-8q 3-10q 65 
a All reactions were carried out with olefin 3-8 (0.20 mmol), CuBr (0.030 mmol), and 3-1 (0.24 
mmol) in CDCl3 (0.6 mL) under Ar at rt for 24 h, unless otherwise stated.  For entry 1, 0.040 
mmol of CuBr was used.  For entry 8, the reaction was carried out on double scale.  b 
Diamination product 3-10q is acid sensitive and was obtained by crystallization from hexanes.  c 
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Isolated yield.  d The reaction was carried out with 8 mmol of olefin 3-8a.  e The ratio of 3-9a to 




 Substrates shown in Figure 3.4 were subjected to internal diamination conditions using 
CuBr but displayed very low conversion or polymerization as judged by 1H NMR of the crude 
reaction mixtures. Radical-stabalizing dienes, such as trienes, gave mixtures of internal and 
terminal diamination products when reacted under CuBr conditions (Figure 3.5). Trisubstituted 
diene substrates generally gave high conversion but presented difficulty when purified on acidic 
silica gel. Attempts at recrystallization in lieu of silica gel chromatography yielded product 7q 
(Table 3.3, entry 8) in good yield but purification of other diamination products proved very 











3.2.2 Mechanistic Hypothesis  
 Although a precise reaction mechanism awaits further study, it is proposed that the 
regioselective diamination of conjugated dienes using 3-1 is analogous to the Cu-catalyzed 
reaction employing 1-17.2 As shown in Scheme 3.7, the Cu(I) catalyst inserts into the N-N bond 
of thiadiaziridine 3-1 to form an equilibrium between Cu(II) radical species 3-12 and Cu(III) 
species 3-13. Terminal diamination is proposed to proceed via a radical pathway. Terminal 
attack of species 3-12 onto the conjugated diene yields another equilibrium of Cu(II) radical 
species 3-14 and Cu(III) species 3-15. Either through radical recombination or reductive 
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elimination, terminal diamination product 3-9 is formed and the Cu(I) catalyst is regenerated. 
Internal diamination is proposed to stem from Cu(III) species 3-13 and resemble a more 
concerted process, similar to that of Pd-catalyzed diene diamination. Coordination of Cu(III) 
species 3-13 to the diene substrate and migratory insertion of the first nitrogen forms (π-allyl)Cu 




 Addition of ligand promotes terminal diamination through coordination of the ligand to 
the Cu center which in turn hinders coordination of the diene to Cu(III) species 3-13, retarding 
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internal diamination. With respect to reaction concentration, a more dilute reaction mixture 
favors internal diamination as it facilitates the intermolecular coordination of species 3-13 with 
the diene substrate. Along with reaction conditions, type of diene also influences regioselectivity. 
Alkyl dienes present a class of dienes that are suitable for either terminal or internal diamination 
and regioselectivity can be tuned based upon reaction conditions. Dienes which possess radical 
stabilizing groups such as aryl groups and trienes are particularly reactive for terminal 
diamination. Electron-rich dienes, such as polysubstituted dienes, display high reactivity and 
regioselectivity towards internal diamination, analogous to the Pd-catalyzed diamination of 
dienes. Substitution of the terminal olefins of entries 4-8 (Table 3.3) could also play a role in 
favoring internal selectivity over terminal. 
3.3 CONCLUSION 
 In summary, a variety of conjugated dienes have been regioselectively diaminated 
employing Cu(I) as catalysts and thiadiaziridine 3-1 as nitrogen source. Reaction conditions as 
well as substrate type influence the resulting regioselectivity of diamination with CuCl-P(n-Bu)3 
as catalyst favoring terminal diamination and CuBr as catalyst for internal diamination. Two 
distinct and competing mechanistic pathways are proposed to be responsible for the observed 
regioselectivity with terminal diamination resulting from a radical process and internal 
diamination resulting from a concerted pathway involving a Cu(III) species. The resulting cyclic 
sulfamides are interesting synthetic intermediates as well as desirable targets for medicinal and 
biological studies. This method presents a direct approach to synthesize these compounds from 





Representative terminal diamination using CuCl (Table 3.2, entry 3):  To a 1.5 mL vial 
equipped with a magnetic stir bar was added CuCl (0.0020 g, 0.020 mmol).  The sealed vial was 
evacuated and filled with argon three times, followed by addition of d-chloroform (0.1 mL) and 
tri-n-butylphosphine (0.005 mL, 0.020 mmol).  After the mixture was stirred at room 
temperature for 30 min, (E)-4-phenylbuta-1,3-diene (3-8c) (0.052 g, 0.40 mmol) was added 
followed by N,N-di-tert-butylthiadiaziridine 1,1-dioxide (3-1) (0.099 g, 0.48 mmol).  The 
reaction mixture was stirred at room temperature for 3.5 h and then purified by flash 
chromatography (silica gel, ethyl acetate:hexanes = 1:10) to give terminal cyclic sulfamide 3-9c 
as a white solid (0.130 g, 97%). 
 
Representative internal diamination using CuBr (Table 3.3, entry 6):  To a 1.5 mL vial 
equipped with a magnetic stir bar was added CuBr (0.0043 g, 0.030 mmol).  The sealed vial was 
evacuated and filled with argon three times, followed by addition of d-chloroform (0.6 mL) and 
(E)-2-ethylpenta-1,3-diene (3-8o) (0.019 g, 0.20 mmol).  N,N-di-tert-butylthiadiaziridine 1,1-
dioxide (3-1) (0.050 g, 0.24 mmol) was then added and the reaction mixture was stirred at room 
temperature for 24 h and purified by flash chromatography (silica gel, hexanes, 1:25 ethyl 
acetate:hexanes) to give internal cyclic sulfamide 3-10o as a colorless oil (0.049 g, 81%). 
 
Representative internal diamination using CuBr on gram scale (Table 3.3, entry 1):  To a 
50 mL round bottom flask equipped with a magnetic stir bar was added CuBr (0.171 g, 1.20 
mmol).  The sealed flask was evacuated and filled with argon three times, followed by addition 
of chloroform (24 mL) and (E)-2-ethylpenta-1,3-diene (3-8a) (1.0 g, 8.0 mmol).  N,N-di-tert-
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butylthiadiaziridine 1,1-dioxide (3-1) (1.97 g, 9.6 mmol) was then added and the reaction 
mixture was stirred at room temperature for 24 h and purified by flash chromatography (silica 
gel, hexanes, 1:25 ethyl acetate:hexanes) to give internal cyclic sulfamide 3-10a as a colorless oil 
(1.99 g, 75%). 
 
Deprotection of 3-10a (Scheme 3.6). A mixture of 3-10a (0.040 g, 0.12 mmol) in CF3CO2H-
hexanes (1:1, 1.2 mL) was stirred at room temperature for 7 h and then purified by flash 
chromatography (silica gel, hexanes, 1:4 ethyl acetate:hexanes) to give compound 3-11 as a 




Table 3.2, entry 1 (rc_b5_1) 
 
Pale yellow oil;  IR (film) 1726, 1481, 1397 cm-1;  1H NMR (400 MHz, CDCl3)  5.75-5.60 (m, 
2H), 4.00-3.95 (m, 1H), 3.42 (dd, J = 8.8, 6.4 Hz, 1H), 2.96 (dd, J = 8.8, 3.6 Hz, 1H), 2.07-2.0 
(m, 2H), 1.41 (s, 9H), 1.38 (s, 9H), 1.42-1.22 (m, 6H), 0.88 (t, J = 6.8, 3H);  13C NMR (100 
MHz, CDCl3)  133.4, 131.2, 57.7, 56.3, 55.6, 47.7, 32.1, 31.6, 28.8, 27.5, 22.6, 14.2;  Anal. 










Table 3.2, entry 2 (zbg0330B) 
 
Colorless oil;  IR (film) 1481, 1370, 1291, 1198, 1143, 1038 cm-1; 1H NMR (300 MHz, CDCl3) 
5.78-5.62 (m, 2H), 4.01-3.94 (m, 1H), 3.42 (dd, J = 8.7, 6.3 Hz, 1H), 2.96 (dd, J = 8.7, 4.2 Hz, 
1H), 1.71 (d, J = 4.8 Hz, 3H), 1.41 (s, 9H), 1.38 (s, 9H);  13C NMR (75 MHz, CDCl3) 132.3, 
127.9, 57.7, 56.3, 55.4, 47.5, 28.7, 27.5, 17.7;  Anal. calcd. for C13H26N2O2S:  C 56.90, H 9.55, 





Table 3.2, entry 3 (zbg0327A) 
 
White solid, mp 164-166 oC;  IR (film) 1284, 1196, 1139 cm-1;  1H NMR (300 MHz, CDCl3)  
7.46-7.22 (m, 5H), 6.59 (d, J = 16.2 Hz, 1H), 6.44 (dd, J = 16.2, 8.4 Hz, 1H), 4.20 (ddd, J = 8.4, 
6.3, 3.6 Hz, 1H), 3.54 (dd, J = 8.7, 6.3 Hz, 1H), 3.09 (dd, J = 8.7, 3.6 Hz, 1H), 1.45 (s, 9H), 1.41 
(s, 9H);  13C NMR (100 MHz, CDCl3)  136.2, 131.6, 130.5, 128.8, 128.2, 126.7, 57.7, 56.4, 
55.6, 47.4, 28.7, 27.5;  Anal. calcd. for C18H28N2O2S:  C 64.25, H 8.39, N 8.33;  found:  C 64.14, 










Table 3.2, entry 4 (zbg0343H) 
 
White solid, mp 112-116 oC;  IR (film) 1607, 1512, 1370, 1291, 1249, 1143, 1035 cm-1;  1H 
NMR (300 MHz, CDCl3)  7.33 (d, J = 8.7 Hz, 2H), 6.87 (d, J = 8.7 Hz, 2H), 6.50 (d, J = 15.6 
Hz, 1H), 6.28 (dd, J = 15.6, 8.4 Hz, 1H), 4.21-4.13 (m, 1H), 3.81 (s, 3H), 3.52 (dd, J = 8.7, 6.0 
Hz, 1H), 3.07 (dd, J = 8.7, 3.6 Hz, 1H), 1.44 (s, 9H), 1.40 (s, 9H);  13C NMR (75 MHz, CDCl3)  
159.7, 131.1, 128.9, 128.2, 127.9, 114.3, 57.7, 56.4, 55.9, 55.5, 47.5, 28.8, 27.5;  Anal. calcd. for 





Table 3.2, entry 5 (zbg0424B) 
 
Yellow solid, mp 119-120 oC;  IR (film) 1597, 1518, 1370, 1343, 1291, 1198, 1143, 1037 cm-1;  
1H NMR (300 MHz, CDCl3)  8.17 (d, J = 8.7 Hz, 2H), 7.52 (d, J = 8.7 Hz, 2H), 6.71 (d, J = 
15.6 Hz, 1H), 6.62 (dd, J = 15.6, 6.9 Hz, 1H), 4.23 (ddd, J = 6.9, 6.6, 3.0 Hz, 1H), 3.58 (dd, J  = 
9.0, 6.6 Hz, 1H), 3.10 (dd, J = 9.0, 3.0 Hz, 1H), 1.43 (s, 9H), 1.39 (s, 9H);  13C NMR (75 MHz, 
CDCl3)  147.3, 142.7, 135.4, 129.6, 127.3, 124.2, 57.9, 56.6, 54.9, 47.1, 28.6, 27.5;  Anal. 








Table 3.2, entry 6 (zbg0424A) 
 
White solid, mp 160-162 oC;  IR (film) 3133, 1464, 1396, 1370, 1282, 1201, 1140, 1031 cm-1;  
1H NMR (300 MHz, CDCl3)  7.35 (d, J = 1.8 Hz, 1H), 6.49-6.28 (m, 4H), 4.17-4.09 (m, 1H), 
3.50 (dd, J = 8.7, 6.3 Hz, 1H), 3.07 (dd, J = 8.7, 3.6 Hz, 1H), 1.43 (s, 9H), 1.39 (s, 9H);  13C 
NMR (75 MHz, CDCl3)  152.0, 142.5, 128.8, 120.1, 111.6, 108.8, 57.8, 56.4, 55.0, 47.4, 28.7, 






Table 3.2, entry 7 (zbg0424E) 
 
White solid, mp 81-82 oC;  IR (film) 1725, 1661, 1372, 1299, 1195, 1143, 1038, 678 cm-1;  1H 
NMR (300 MHz, CDCl3)  7.06 (dd, J = 15.3, 6.9 Hz, 1H), 6.13 (d, J = 15.3 Hz, 1H), 4.17-4.09 
(m, 1H), 3.75 (s, 3H), 3.51 (dd, J = 9.3, 6.9 Hz, 1H), 3.03 (dd, J = 9.3, 3.6 Hz, 1H), 1.38 (s, 9H), 
1.36 (s, 9H);  13C NMR (75 MHz, CDCl3)  166.5, 147.9, 122.8, 57.9, 56.6, 53.2, 51.9, 46.2, 










Table 3.2, entry 8 (zbg0424C) 
 
Colorless oil;  IR (film) 1598, 1576, 1397, 1370, 1294, 1197, 1144, 1032, 911 cm-1;  1H NMR 
(300 MHz, CDCl3)  7.46-7.36 (m, 3H), 7.33-7.22 (m, 5H), 7.14-7.10 (m, 2H), 6.46 (d, J = 9.6 
Hz, 1H), 4.08 (ddd, J = 9.6, 6.6, 3.6 Hz, 1H), 3.49 (dd, J = 8.7, 6.6 Hz, 1H), 3.19 (dd, J = 8.7, 3.6 
Hz, 1H), 1.41 (s, 9H), 1.32 (s, 9H);  13C NMR (75 MHz, CDCl3)  142.2, 141.0, 138.7, 129.7, 
129.5, 128.8, 128.5, 128.1, 128.0, 127.5, 57.5, 56.5, 51.7, 47.4, 28.7, 27.5;  Anal. calcd. for 





Table 3.2, entry 9 (zbg0330C) 
 
White solid, mp 58-60 oC;  IR (film) 1481, 1397, 1144 cm-1;  1H NMR (300 MHz, CDCl3)  
5.46-5.40 (m, 1H), 4.26-4.18 (m, 1H), 3.35 (dd, J = 8.4, 6.3 Hz, 1H), 2.88 (dd, J = 8.4, 5.1 Hz, 
1H), 1.70 (d, J = 0.9 Hz, 3H), 1.66 (d, J = 1.2 Hz, 3H), 1.37 (s, 9H), 1.36 (s, 9H);  13C NMR (75 
MHz, CDCl3)  133.4, 126.5, 57.4, 56.3, 51.3, 47.2, 28.7, 27.4, 25.9, 18.0;  Anal. calcd. for 











Table 3.2, entry 10 (zbg0331A) 
 
White solid, mp 126-128 oC;  IR (film) 1367, 1280, 1199, 1141, 998 cm-1;  1H NMR (300 MHz, 
CDCl3)  6.21-6.00 (m, 2H), 5.82-5.68 (m, 2H), 4.05-3.97 (m, 1H), 3.44 (dd, J = 9.0, 6.0 Hz, 
1H), 2.98 (dd, J = 9.0, 4.2 Hz, 1H), 1.76 (d, J = 6.9 Hz, 3H), 1.41 (s, 9H), 1.38 (s, 9H);  13C 
NMR (75 MHz, CDCl3)  132.1, 131.2, 131.1, 130.5, 57.7, 56.4, 55.4, 47.5, 28.7, 27.5, 18.3;  





Table 3.2, entry 11 (zbg0314) 
 
Colorless oil;  IR (film) 1397, 1294, 1143 cm-1;  1H NMR (300 MHz, CDCl3)  6.25-5.94 (m, 
2H), 5.82-5.65 (m, 2H), 4.05-3.97 (m, 1H), 3.44 (dd, J = 8.4, 6.3 Hz, 1H), 2.98 (dd, J = 8.4, 3.6 
Hz, 1H), 2.07 (q, J = 6.9 Hz, 2H), 1.40 (s, 9H), 1.37 (s, 9H), 1.41-1.22 (m, 6H), 0.88 (t, J = 6.9 
Hz, 3H);  13C NMR (75 MHz, CDCl3)  136.7, 132.2, 131.2, 128.9, 57.7, 56.3, 55.4, 47.5, 32.8, 












Table 3.3, entry 1 (rc_b5_5_0) 
 
Pale yellow oil;  IR (film) 1467, 1290, 1196, 1143 cm-1;  1H NMR (300 MHz, CDCl3)  6.13-
5.98 (ddd, J = 17.1, 10.5, 6.6 Hz, 1H), 5.34 (d, J = 17.1 Hz, 1H), 5.19 (d, J = 10.5 Hz, 1H), 3.74 
(d, J = 6.6 Hz, 1H), 3.06 (dd, J = 11.4, 3.0 Hz, 1H), 1.95-1.79 (m, 1H), 1.65-1.52 (m, 1H), 1.39 
(s, 9H), 1.37 (s, 9H), 1.41-1.25 (m, 6H), 0.93-0.84 (m, 3H);  13C NMR (100 MHz, CDCl3)  
139.7, 116.5, 60.4, 60.1, 57.0, 56.9, 36.1, 31.7, 28.9, 25.9, 22.7, 14.1;  Anal. calcd. for 





Table 3.3, entry 2 (rc_b5_5_16) 
 
White solid, mp 78-80 oC;  IR (film) 1370, 1280, 1252, 1139 cm-1;  1H NMR (300 MHz, CDCl3) 
 6.13-6.01 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 5.37 (dd, J = 17.1, 0.6 Hz, 1H), 5.21 (dd, J = 10.2, 
0.6 Hz, 1H), 3.61 (d, J = 6.9 Hz, 1H), 3.33 (q, J = 6.6 Hz, 1H), 1.42 (d, J = 6.6 Hz, 3H), 1.41 (s, 
9H), 1.39 (s, 9H);  13C NMR (100 MHz, CDCl3)  139.1, 116.7, 63.3, 56.9, 55.8, 29.0, 28.9, 











Table 3.3, entry 3 (rc_b5_7) 
 
Yellow oil;  IR (film) 1364, 1220, 1156 cm-1;  1H NMR (300 MHz, CDCl3)  6.24 (dd, J = 17.4, 
10.8 Hz, 1H), 5.40 (d, J = 17.4 Hz, 1H), 5.27 (d, J = 10.8 Hz, 1H), 4.93 (s, 1H), 4.08-3.99 (m, 
1H), 3.63-3.50 (m, 1H), 2.08-2.00 (m, 1H), 1.88-1.70 (m, 3H), 1.45 (s, 9H), 1.31 (s, 9H);  13C 
NMR (100 MHz, CDCl3)  139.3, 116.3, 87.7, 81.6, 58.0, 57.3, 55.5, 32.0, 28.7, 28.3, 17.8;  





Table 3.3, entry 4 (rc_b5_24_2d) 
 
Colorless oil;  IR (film) 1371, 1289, 1197, 1144 cm-1;  1H NMR (400 MHz, CDCl3)  5.40 (s, 
1H), 5.02 (s, 1H), 3.51 (s, 1H), 3.08 (dd, J = 11.6, 2.4 Hz, 1H), 1.97-1.83 (m, 1H), 1.75 (s, 3H), 
1.69-1.59 (m, 1H), 1.39 (s, 9H), 1.40 (s, 9H), 1.37-1.24 (m, 8H), 0.89 (t, J = 6.0 Hz, 3H);  13C 
NMR (100 MHz, CDCl3)  144.0, 114.0, 62.5, 58.9, 56.9, 56.6, 36.5, 31.9, 29.3, 29.21, 28.19, 
26.3, 22.8, 19.4, 14.3;  Anal. calcd. for C19H38N2O2S:  C 63.64, H 10.68, N 7.81;  found:  C 










Table 3.3, entry 5 (rc_b5_5_6) 
 
Pale yellow oil;  IR (film) 1371, 1289, 1251, 1144 cm-1;  1H NMR (300 MHz, CDCl3)  5.40 (s, 
1H), 4.87 (s, 1H), 3.45 (q, J = 6.6 Hz, 1H), 3.34 (s, 1H), 1.66 (d, J = 14.7 Hz, 1H), 1.43 (d, J = 
6.6 Hz, 3H), 1.41 (s, 9H), 1.35 (s, 9H), 1.22 (d, J = 14.7 Hz, 1H), 0.07 (s, 9H);  13C NMR (100 
MHz, CDCl3)  144.4, 111.9, 66.1, 56.7, 56.5, 53.9, 29.2, 28.4, 24.1, 23.2, -0.68;  Anal. calcd. 




Table 3.3, entry 6 (rc_b5_14_19) 
 
Colorless oil;  IR (film) 1398, 1287, 1143 cm-1;  1H NMR (300 MHz, CDCl3)  5.44 (s, 1H), 4.99 
(s, 1H), 3.44 (s, 1H), 3.32 (q, J = 6.6 Hz, 1H), 2.16-1.92 (m, 2H), 1.43 (d, J = 6.6 Hz, 3H), 1.38 
(s, 9H), 1.35 (s, 9H), 1.10 (t, J = 7.2 Hz, 3H);  13C NMR (100 MHz, CDCl3)  149.9, 111.3, 65.0, 
56.8, 56.7, 54.7, 29.3, 28.2, 25.6, 24.0, 12.4;  Anal. calcd. for C15H30N2O2S:  C 59.56, H 10.00, 











Table 3.3, entry 7 (rc_b5_5_13) 
 
Yellow oil;  IR (film) 1715, 1302, 1194, 1151, 1070 cm-1;  1H NMR (400 MHz, C6D6)  4.34 (s, 
1H), 3.64 (s, 1H), 2.91 (s, 1H), 2.25 (s, 1H), 1.28 (s, 9H), 1.21 (s, 9H);  13C NMR (100 MHz, 
C6D6)  209.4, 87.0, 67.0, 66.9, 58.4, 57.6, 53.0, 52.9, 29.5, 28.2, 26.6;  Anal. calcd. for 





Table 3.3, entry 8 (rc_b5_18_24) 
 
White solid, mp 84-86 oC;  IR (film) 1255, 1214, 1104 cm-1;  1H NMR (400 MHz, CDCl3)  5.12 
(s, 1H), 4.99 (s, 1H), 3.89 (q, J = 6.4 Hz, 1H), 1.91 (s, 3H), 1.43 (s, 9H), 1.39 (s, 3H), 1.39 (d, J 
= 6.4 Hz, 3H), 1.32 (s, 9H);  13C NMR (100 MHz, CDCl3)  146.9, 112.2, 87.8, 58.3, 57.3, 55.3, 
31.9, 29.2, 23.0, 19.6, 18.9;  Anal. calcd. for C15H30N2O2S:  C 59.56, H 10.00, N 9.26;  found:  C 












Scheme 3.6 (rc_b5_20_1to1) 
 
Yellow oil;  IR (film) 3255, 1302, 1168 cm-1;  1H NMR (300 MHz, CDCl3)  5.80 (ddd, J = 16.8, 
10.5, 7.5 Hz, 1H), 5.40 (d, J = 16.8 Hz, 1H), 5.33 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 6.0 Hz, 1H), 
4.54 (d, J = 8.4 Hz, 1H), 3.96-3.80 (m, 1H), 3.52-3.41 (m, 1H), 1.75-1.24 (m, 8H), 0.89 (t, J = 
6.9 Hz, 3H);  13C NMR (100 MHz, CDCl3)  133.8, 120.8, 66.4, 63.0, 32.3, 31.6, 26.4, 22.6, 
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4.1 GENERAL INTRODUCTION 
 The cyclic sulfamide motif is a promising functional group in the area of medicinal 
chemistry as they have shown to exhibit interesting biological activity as HIV protease 
inhibitors, anti-inflammatory agents, antibacterials, blood pressure regulators, enzyme inhibitors, 
and treatments for Alzheimer’s disease (Figure 4.1).1 Cyclic sulfamides have also been used as 
chiral control agents in asymmetric aldol reactions and alkylations.2 
 
Figure 4.1 
4.2 CURRENT METHODS TO SYNTHESIZE CHIRAL CYCLIC SULFAMIDES 
 Due to the potential significance that cyclic sulfamides possess for biological studies, 
methods for their asymmetric synthesis have been reported. Commonly used methods employ 
multistep syntheses from chiral amino acids.1f,3 In 2000, Dewynter and coworkers reported the 
synthesis of chiral cyclosulfamides from amino acid methyl esters and chlorosulfonyl isocyanate 
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(Scheme 4.1).3a Good yields were obtained in four steps while maintaining the starting material 
chirality and providing substitution at the 3-position. 
 
Scheme 4.1 
 Kim and Jung synthesized cyclic sulfamide 4-6 from (S)-(+)-phenylglycinol (4-1) 
(Scheme 4.2). After Cbz protection of the nitrogen and activation of the alcohol with MsCl, the 
amino azide 4-4 was obtained.4 Reduction of the azide and deprotection occurred in one step 
using H2/Pd-C to give diamine 4-5. Catecholsulfate was employed to form cyclic sulfamide 4-6 
in five steps overall. 
 
Scheme 4.2 
 More recently, Lee and coworkers reported a highly enantioselective synthesis of cyclic 
sulfamides via asymmetric hydrogenation of thiadiazole 1,1-dioxides (Figure 4.2).5 Starting from 
94 
 
α-hydroxy aryl ketones, condensation of sulfamide gave the parent thiadiazole 1,1-dioxides 4-8. 
Asymmetric hydrogenation using chiral catalyst 4-10 gave the chiral cyclic sulfamides in high 
yield and mostly high ee’s. This process allowed substitution on the sulfamide ring to vary from 
naturally occurring amino acids, however it was still limited to aryl groups. 
 
Figure 4.2 
 Chiral cyclic sulfamides can be obtained through the abovementioned methods, however 
substrate variability is limited to naturally occurring amino acid side chains or aryl groups and 
multiple steps are needed in the syntheses. It was envisioned that asymmetric diamination using 
thiadiaziridine 3-1 (Figure 4.3) could provide a direct and viable route to chiral cyclic sulfamides 
and greatly expand the substitution possibilities. The following chapter describes the asymmetric 






4.3 RESULTS AND DISCUSSION  
4.3.1 Reaction Conditions and Substrate Scope 
 (E)-nona-1,3-diene was chosen as a test substrate for screening initial asymmetric 
diamination conditions. Various phosphoramidite and TADDOL-derived ligands were 
synthesized using known procedures as exemplified in Scheme 4.3.6 Catalysts generated from 
Pd2(dba)3 and a chiral ligand were screened for reactivity and selectivity (Figure 4.4).7 As shown 
in Figure 4.4, bidentate ligand R-BINAP (4-11) displayed no reaction. TADDOL-derived ligand 
4-12 gave promising ee, while ligand 4-13 gave good reactivity but low selectivity. BINOL-
based phosphoramidite ligands gave the most promising selectivity and diamination occurred 





Ligand 4-15 displayed moderate reactivity with good selectivity. Interestingly, ligands 4-16 and 
4-17, which had shown to be optimal for asymmetric diamination of dienes using nitrogen source 
1-17,8 displayed diminished selectivity using nitrogen source 3-1. Ligand 4-18, having 
previously been less reactive using 1-17, gave very promising selectivity and reactivity with 3-1, 
providing the cyclic sulfamide 4-22d in 76% yield and 90% ee. Diastereomeric ligand 4-19 gave 
comparable yield but selectivity was lower, indicating a matched/mismatched relationship 
between the BINOL and amine portions of the ligand necessary for high asymmetric induction. 
Comparison of biphenyl ligand 4-14 with the reactive ligand 4-18 shows that the resulting 
stereochemistry of the sulfamide products is determined by the BINOL skeleton and not the 
amine portion. The hydrogenated ligand 4-20, with the opposite stereochemistry of ligand 4-18, 





 Using ligand 4-18 and upon further screening of reaction parameters, investigation into 
the substrate scope was carried out. A variety of (E)-alkyl-substituted conjugated dienes were 
efficiently diaminated at the internal double bond under the reaction conditions in good to high 
yield and provided enantioselectivities above 90% (Table 4.1). No diamination product was 





Table 4.1 Catalytic Asymmetric Diamination of Conjugated Dienes to Form Cyclic Sulfamides 












4-21a, R= Me 
4-21b, R= n-Pr 
4-21c, R= i-Bu 
4-21d, R= n-C5H11 
4-21e, R= n-C10H21 
4-21f, R= (CH2)2Cy 

































4-21i, Ar= Ph 













4-21k, R= n-C6H13 
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a All reactions were carried out with diene 4-21 (0.20 mmol), 3-1 (0.30 mmol), Pd2(dba)3 
(0.005 mmol), and 4-18 (0.02 mmol) in toluene (0.10 mL) under Ar at 65 oC for 3 h, unless 
otherwise stated.  b For entries 4 and 8, the absolute configurations (R,R) were determined by 
comparison of the optical rotations with reported ones after complete deprotection to the free 
diamine (ref. 8a, 9). For all other entries, the absolute configurations were not determined and 
the stereochemistry indicated represents relative stereochemistry.  c Isolated yield.  d The ee was 
determined by chiral HPLC (Chiralpak IC column) after removal of the t-Bu groups, unless 
otherwise stated.  e The ee was determined without removal of the t-Bu groups.  f The reaction 
was carried out with diene 4-21i (6.96 mmol), 3-1 (9.03 mmol), Pd2(dba)3 (0.10 mmol), and 4-18 
(0.46 mmol) in toluene (3.5 mL) under Ar at 65 oC for 3 h.  g Reaction time, 6 h.  h The ee was 
determined by chiral HPLC (Chiralpak IA column). 
 
The reaction conditions are suitable for substrates with substitution on the alkyl chains such as 
silyl (Table 4.1, entry 7) and aryl groups (Table 4.1, entries 8-10) as well as ethers (Table 4.1, 
entries 11-13). Spectator double bonds were also left unreacted in geometrically pure form 
(Table 4.1, entries 14-15). The catalytic asymmetric diamination was also run on gram scale with 
catalyst loading being reduced to 1.4 mol% Pd2(dba)3 (Table 4.1, entry 8). 
 The diene substrates were synthesized from readily available α,β-unsaturated aldehydes 
and MePPh3Br. In order to obtain strictly pure trans-dienes, other methods were employed to 
synthesize certain substrates (Schemes 4.4-4.6). Olefins 4-21c and 4-21f-j were prepared using 
preformed diethyl allylphosphonate and the corresponding aldehydes (Scheme 4.4).10 The 
resulting selectivity for trans and cis isomers was >20:1 as judged by 1H NMR. 1-Chloro-2,4-
pentadiene was synthesized with complete trans selectivity from 1,4-pentadien-3-ol and conc. 
HCl (Scheme 4.5). Reaction with the appropriate alcohol and K2CO3 gave the corresponding 
trans dienes 4-21k and 4-21l in good yield (Scheme 4.5).11 Lastly, olefin 4-21m was synthesized 
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via base-mediated double bond isomerization followed by reduction of the diene ester (Scheme 









 Using ligands 4-18 and 4-20, diene 4-21g was diaminated asymmetrically to give both 
enantiomers of the resulting cyclic sulfamide in good yield and selectivity (Scheme 4.7). The X-
ray structure of product 4-22g was obtained via X-ray diffraction of a single crystal, confirming 









 Alkyl dienes proved to be the most reactive substrate class. The dienes shown in Figure 
4.6 proved reactive, however enantioselectivity was unable to be obtained because the racemic 
reaction using CuBr gave no racemic diamination product. The dienes shown in Figure 4.7 were 
also subjected to the reaction conditions but low conversion or no diamination was observed. 







Facile removal of the tert-butyl groups from the resulting cyclic sulfamide products was 
accomplished using a mixture of CF3CO2H-hexanes at room temperature (Scheme 4.8). This 
provided access for possible derivatization of the sulfamide nitrogens. Both tert-butyl groups and 
the sulfone group were removed in one step by refluxing in aqueous HBr to yield the free 
diamine (Scheme 4.8).14 
 
Scheme 4.8 
4.3.2 Mechanistic Hypothesis 
 The catalytic asymmetric diamination of conjugated dienes using 3-1 as nitrogen source 
is proposed to be very similar and analogous to the Pd-catalyzed asymmetric diamination of 
dienes using 1-17 as nitrogen source (Scheme 4.9). Initially, the Pd(0) complex inserts into the 
N-N bond of thiadiaziridine 3-1 to give four-membered Pd complex 4-25. Coordination of this 
complex with the diene substrate (4-26) and migratory insertion of one nitrogen gives π-allyl Pd 






4.3.3 Attempt at Asymmetric Terminal Diamination 
 Also of interest would be the development of an asymmetric dehydrogenative 
diamination to give chiral terminal diamination products (Scheme 4.10). 1-Nonene was chosen 
as test substrate and various chiral phosphoramidite ligands were employed with Pd2(dba)3 to 
investigate the terminal diamination (Figure 4.8).15 No conversion was obtained using ligands 4-
28 and 4-29. Variation of the nitrogen portion of the ligand increased conversion and gave 
differing ratios for the terminal and internal products. Ligand 4-32 gave moderate conversion 
with high selectivity for terminal diamination. Diisopropyl amine (4-33) and dicyclohexyl amine 









Ligand 4-11 gave good conversion and a ratio of 4 : 1, internal to terminal diamination (Scheme 
4.11), and careful separation of the two isomers was performed via silica gel chromatography. 
Removal of the tert-butyl groups in CF3CO2H:hexanes allowed separation via HPLC. It was 
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found that the internal diamination product was obtained in 87% ee, while the terminal 
diamination product was racemic (Scheme 4.11). The terminal asymmetric dehydrogenative 





 Cyclic sulfamides are important functional motifs which exhibit potentially very useful 
biological activity when incorporated into peptide scaffolds as well as small molecules. Current 
routes for their asymmetric synthesis limit substitution on the sulfamide ring to natural amino 
acid side chains and aryl groups. Using the above route, chiral cyclic sulfamides are synthesized 
directly in one step from readily available alkyl-substituted dienes using Pd and ligand 4-18 as 
catalyst, and 3-1 as nitrogen source. The resulting cyclic sulfamides are obtained in good yield 
and high ee with a variety of substitution and a pendant vinyl group for further manipulation. 
Using the opposite enantiomer ligand provides complementary enantioselectivity for the cyclic 
sulfamide products. The resulting cyclic sulfamides can be deprotected to yield the free diamine 
while maintaining ee. It is proposed that utilization of this method will provide greater access to 
more structural variety in the synthesis of these chiral compounds and lead to more biological 




Representative catalytic asymmetric diamination procedure (Table 4.1, entry 1):  To a 
flame-dried 1.5 mL vial equipped with a magnetic stir bar was added Pd2(dba)3 (0.0046 g, 0.005 
mmol) and 4-18 (0.0108 g, 0.02 mmol).  The sealed vial was evacuated and filled with argon 
three times, followed by addition of toluene (0.1 mL, distilled from sodium).  The mixture was 
immersed in an oil bath (65 oC) and stirred for 10 min.  trans-Penta-1,3-diene (4-21a) (0.0136 g, 
0.20 mmol) was added followed by N,N’-di-tert-butylthiadiaziridine 1,1-dioxide (3-1) (0.062 g, 
0.30 mmol) in one portion and the reaction mixture was stirred at 65 oC for 3 h.  The crude 
product was purified by flash chromatography (silica gel, 25:1 hexanes: ethyl acetate).  A second 
column was used to remove excess dba (silica gel, toluene until the yellow color elutes, then 25:1 
hexanes: ethyl acetate).  Cyclic sulfamide 4-22a was obtained as a white solid (0.053 g, 97% 
yield, 90% ee). 
 
Representative diamination on gram scale (Table 4.1, entry 9):  To a flame-dried 15 mL vial 
equipped with a magnetic stir bar was added Pd2(dba)3 (0.0915 g, 0.10 mmol) and 4-18 (0.2476 
g, 0.46 mmol).  The sealed vial was evacuated and filled with argon three times, followed by 
addition of toluene (3.5 mL, distilled from sodium).  The mixture was immersed in an oil bath 
(65 oC) and stirred for 10 min.  trans-1-Phenyl-hexa-3,5-diene (4-21i) (1.10 g, 6.96 mmol) was 
added followed by N,N’-di-tert-butylthiadiaziridine 1,1-dioxide (3-1) (1.86 g, 9.03 mmol) in one 
portion and the reaction mixture was stirred at 65 oC for 3 h. The crude product was purified by 
flash chromatography (silica gel, 15:1 (v/v) hexanes: ethyl acetate). A second column was used 
to remove excess dba (silica gel, toluene until the yellow color elutes, then 15:1 (v/v) hexanes: 
ethyl acetate). Cyclic sulfamide 4-22i was obtained as a white solid (2.24 g, 88% yield, 92% ee). 
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Representative procedure for removal of t-Butyl groups (Scheme 4.8).  A mixture of 
sulfamide 4-22h (0.094 g, 0.27 mmol) in CF3CO2H-hexanes (1:1 (v/v), 2.4 mL) was stirred at 
room temperature for 7 h, concentrated, and subsequently purified by flash chromatography 
(silica gel, 4:1 (v/v) hexanes: ethyl acetate) to give compound 4-23h as a white solid (0.058 g, 
91% yield, 93% ee). 
Cornwall, R.G.; Zhao, B.; Shi, Y. Org. Lett. 2011, 13, 434.  
 
Representative procedure for deprotection to free diamine (Scheme 4.7).  To a 25 mL round-
bottom flask equipped with a magnetic stir bar and reflux condenser was added sulfamide 4-22h 
(0.258 g, 0.736 mmol) and phenol (0.263 g, 2.79 mmol).  2N HBr (8.5 mL) was added and the 
mixture was vigorously refluxed for 24 h. The reaction was allowed to cool to room temperature 
and washed with Et2O to remove excess phenol as monitored by TLC. The acidic aqueous layer 
was made basic with solid NaOH and extensively extracted with Et2O as monitored by TLC.  
The combined organic layers were dried over Na2SO4, filtered, and concentrated to yield diamine 
4-24h as a pale yellow oil (0.114 g, 88% yield, 93% ee). 
Pansare, S.V.; Rai, A.N.; Kate, S.N. Synlett 1998, 623. 
 
The ee of free diamine 4-24h was determined after derivatization to the di-m-toluoyl amide 
by the following procedure:  To a 5 mL vial charged with diamine 4-24h (0.008 g, 0.045 mmol) 
was added NaOH solution (2.0 M, 0.27 mL, 0.54 mmol) and CH2Cl2 (1.2 mL).  Upon stirring at 
rt for 2 min, m-toluoyl chloride (0.015 g, 0.10 mmol) was added via syringe and the resulting 
mixture was stirred at rt for 10 min.  A portion (30 μL) of the organic layer was diluted with 
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Hex/IPA (1:1) (2 mL) and submitted to HPLC analysis (Chiralpak IC column, Hex:IPA 95:5, 
1mL/min). 
Zhao, B.; Peng, X.; Cui, S.; Shi, Y. J. Am. Chem. Soc. 2010, 132, 11009 
Table 4.1, entry 1 (rc_b8_6_1) 
 
White solid;  mp 91-95 oC;  [α]20D= +39.1 (c 1.0, CHCl3) (90% ee);  IR (film) 1371, 1275, 1138 
cm-1;  1H NMR (300 MHz, CDCl3)  6.07 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 5.37 (d, J = 17.1 Hz, 
1H), 5.21 (d, J = 10.2 Hz, 1H), 3.61 (d, J = 6.9 Hz, 1H), 3.34 (q, J = 6.6 Hz, 1H), 1.42 (d, J = 6.6 
Hz, 3H), 1.41 (s, 9H), 1.39 (s, 9H);  13C NMR (100 MHz, CDCl3)  139.1, 116.7, 63.3, 56.91, 
56.89, 55.8, 29.0, 28.9, 22.9;  HRMS calcd. for C13H26N2NaO2S (M+Na)+: 297.1607.  Found: 
297.1603. 
Cornwall, R.G.; Zhao, B.; Shi, Y. Org. Lett. 2011, 13, 434.  
 
Table 4.1, entry 2 (rc_b8_6_3) 
 
Pale yellow oil;  [α]20D= +82.4 (c 0.71, CHCl3) (90% ee);  IR (film) 1644, 1398, 1290 cm-1;  1H 
NMR (300 MHz, CDCl3)  6.07 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 5.34 (dd, J = 17.1, 0.6 Hz, 
1H), 5.20 (dd, J = 10.2, 0.6 Hz, 1H), 3.76 (d, J = 6.9 Hz, 1H), 3.10 (dd, J = 11.1, 2.7 Hz, 1H), 
1.98-1.81 (m, 1H), 1.66-1.51 (m, 1H), 1.44-1.36 (m, 2H), 1.40 (s, 9H), 1.39 (s, 9H), 0.97 (t, J = 
7.8 Hz, 3H);  13C NMR (75 MHz, CDCl3)  139.7, 116.5, 60.1, 57.0, 56.9, 38.2, 28.9, 19.4, 14.0;  
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Anal. calcd. for C15H30N2O2S: C, 59.56; H, 10.00; N, 9.26.  Found: C, 59.33; H, 9.79; N, 9.41. 
 
Table 4.1, entry 3 (rc_b9_32_1) 
 
White solid;  mp 51-54 oC;  [α]20D= +29.7 (c 0.37, CHCl3) (90% ee);  IR (film) 1469, 1290, 1143 
cm-1; 1H NMR (300 MHz, CDCl3)  6.07 (ddd, J = 16.8, 10.2, 6.6 Hz, 1H), 5.34 (d, J = 16.8 Hz, 
1H), 5.20 (d, J = 10.2 Hz, 1H), 3.75 (d, J = 6.9 Hz, 1H), 3.20 (dd, J = 11.7, 2.4 Hz, 1H), 2.07-
1.88 (m, 1H), 1.75-1.57 (m, 2H), 1.39 (s, 9H), 1.38 (s, 9H), 0.97 (d, J = 6.6 Hz, 3H), 0.93 (d, J = 
6.6 Hz, 3H);  13C NMR (75 MHz, CDCl3)  139.6, 116.5, 60.0, 58.7, 57.1, 56.8, 44.9, 29.0, 28.8, 
25.7, 24.2, 21.3.  Anal. calcd. for C16H32N2O2S: C, 60.72; H, 10.19; N, 8.85.  Found: C, 60.90; 
H, 9.91; N, 8.86. 
 
Table 4.1, entry 4 (rc_b8_6_10) 
 
Pale yellow oil;  [α]20D= +25.6 (c 0.5, CHCl3) (91% ee);  IR (film) 1468, 1290, 1196, 1143 cm-1;  
1H NMR (300 MHz, CDCl3)  6.07 (ddd, J = 17.1, 10.2, 6.6 Hz, 1H), 5.35 (d, J = 17.1 Hz, 1H), 
5.20 (d, J = 10.2 Hz, 1H), 3.75 (d, J = 6.6 Hz, 1H), 3.07 (dd, J = 11.4, 2.7 Hz, 1H), 1.98-1.80 (m, 
1H), 1.66-1.52 (m, 1H), 1.39 (s, 9H), 1.37 (s, 9H), 1.41-1.25 (m, 6H), 0.95-0.84 (m, 3H);  13C 
NMR (75 MHz, CDCl3)  139.7, 116.5, 60.4, 60.1, 57.0, 56.9, 36.1, 31.7, 28.9, 25.9, 22.7, 14.1.  
Anal. calcd. for C17H34N2O2S: C, 61.77; H, 10.37; N, 8.48.  Found: C, 61.92; H, 10.17; N, 8.56. 
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Cornwall, R.G.; Zhao, B.; Shi, Y. Org. Lett. 2011, 13, 434.  
 
Table 4.1, entry 5 (rc_b8_6_4) 
 
Pale yellow oil;  [α]20D= +19.3 (c 7, CHCl3) (83% ee);  IR (film) 2926, 2855, 1293, 1143 cm-1;  
1H NMR (300 MHz, CDCl3)  6.06 (ddd, J = 17.4, 10.5, 7.2 Hz, 1H), 5.35 (d, J = 17.4 Hz, 1H), 
5.20 (d, J = 10.5 Hz, 1H), 3.75 (d, J = 6.6 Hz, 1H), 3.07 (dd, J = 11.1, 2.4 Hz, 1H), 2.00-1.78 (m, 
1H), 1.66-1.52 (m, 1H), 1.41 (s, 9H), 1.39 (s, 9H), 1.40-1.20 (m, 11H), 0.88 (t, J = 6.3 Hz, 1H);  
13C NMR (100 MHz, CDCl3)  139.7, 116.5, 60.5, 60.1, 57.0, 56.9, 36.1, 32.1, 29.8, 29.72, 
29.70, 29.52, 29.51, 29.0, 26.2, 22.9, 14.3.  Anal. calcd. for C22H44N2O2S: C, 65.95; H, 11.07; N, 
6.99.  Found: C, 66.07; H, 10.91; N, 6.89. 
 
Table 4.1, entry 6 (rc_b9_32_2) 
 
Colorless oil;  [α]20D= +24.3 (c 0.75, CHCl3) (91% ee);  IR (film) 1291, 1143 cm-1;  1H NMR 
(300 MHz, CDCl3)  6.05 (ddd, J = 16.8, 10.2, 6.9 Hz, 1H), 5.36 (dd, J = 16.8, 0.9 Hz, 1H), 5.19 
(dd, J = 10.2, 0.9 Hz, 1H), 3.73 (d, J = 6.9 Hz, 1H), 3.02 (dd, J = 11.1, 2.4 Hz, 1H), 1.97-1.81 
(m, 1H), 1.80-1.54 (m, 6H), 1.40 (s, 9H), 1.38 (s, 9H), 1.28-1.12 (m, 6H), 0.80-0.99 (m, 2H);  
13C NMR (100 MHz, CDCl3)  139.6, 116.5, 60.9, 60.0, 56.9, 56.8, 37.8, 34.1, 33.8, 33.6, 33.3, 
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28.91, 28.89, 26.7, 26.5, 26.4;  Anal. calcd. for C20H38N2O2S: C, 64.82; H, 10.34; N, 7.56.  
Found: C, 64.64; H, 10.49; N, 7.28. 
 
Table 4.1, entry 7 (rc_b9_10_3) 
 
White solid;  mp 129-131 oC;  [α]20D= +30.0 (c 0.83, CHCl3) (91% ee); IR (film) 1279 cm-1;  1H 
NMR (300 MHz, CDCl3)  6.06 (ddd, J = 17.1, 10.5, 6.6 Hz, 1H), 5.38 (d, J = 17.1 Hz, 1H), 
5.21 (d, J = 10.5 Hz, 1H), 3.81 (d, J = 6.6 Hz, 1H), 2.97 (dd, J = 10.8, 2.7 Hz, 1H), 1.87-1.68 (m, 
1H), 1.64-1.48 (m, 1H), 1.40 (s, 9H), 1.38 (s, 9H), 0.54 (td, J = 13.5, 4.2 Hz, 1H), 0.39 (td, J = 
13.5, 4.2 Hz, 1H), 0.01 (s, 9H);  13C NMR (100 MHz, CDCl3)  139.8, 116.5, 63.4, 59.4, 56.9, 
30.5, 28.93, 28.90, 13.4, -1.66;  HRMS calcd. for C17H36N2NaO2SSi (M+Na)+: 383.2159.  
Found: 383.2153. 
 
Table 4.1, entry 8 (rc_b9_10_1) 
 
White solid;  mp 86-88 oC;  [α]20D= +23.3 (c 0.90, CHCl3) (93% ee);  IR (film) 1398, 1292, 1143 
cm-1;  1H NMR (400 MHz, CDCl3)  7.39-7.33 (m, 2H), 7.31-7.25 (m, 1H), 7.24-7.19 (m, 2H), 
5.95 (ddd, J = 17.2, 10.4, 6.8 Hz, 1H), 5.08 (d, J = 10.4 Hz, 1H), 5.04 (d, J = 17.2 Hz, 1H), 3.75 
(d, J = 6.8 Hz, 1H), 3.48 (dd, J = 10.8, 4.4 Hz, 1H), 3.10 (dd, J = 14.0, 4.4 Hz, 1H) 3.03 (dd, J = 
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14.0, 10.8 Hz, 1H), 1.46 (s, 9H), 1.44 (s, 9H);  13C NMR (100 MHz, CDCl3)  139.4, 137.8, 
129.2, 129.1, 127.2, 116.7, 61.4, 59.3, 57.5, 57.1, 42.0, 29.2, 29.0;  HRMS calcd. for 
C19H30N2NaO2S (M+Na)+: 373.1920.  Found: 373.1923. 
 
Table 4.1, entry 9 (rc_b9_10_2) 
 
White solid;  mp 50-54 oC;  [α]20D= +20.0 (c 0.39, CHCl3) (92% ee);  IR (film) 1454, 1286, 1142 
cm-1;  1H NMR (300 MHz, CDCl3)  7.34-7.12 (m, 5H), 6.03 (ddd, J = 16.8, 10.2, 6.9 Hz, 1H), 
5.33 (d, J = 16.8 Hz, 1H), 5.21 (d, J = 10.2 Hz, 1H), 3.75 (d, J = 6.8 Hz, 1H), 3.10 (dd, J = 10.8, 
2.4 Hz, 1H), 2.86-2.72 (m, 1H), 2.70-2.57 (m, 1H), 2.34-2.17 (m, 1H), 2.20-1.86 (m, 1H), 1.40 
(s, 9H), 1.31 (s, 9H);  13C NMR (100 MHz, CDCl3)  140.6, 139.2, 128.8, 128.6, 126.5, 116.8, 
60.1, 59.5, 57.1, 56.9, 37.4, 32.6, 29.0, 28.8;  HRMS calcd. for C20H32N2NaO2S (M+Na)+: 










Table 4.1, entry 10 (rc_b9_10_5) 
 
Yellow solid;  mp 46-50 oC;  [α]20D= +11.8 (c 0.60, CHCl3) (90% ee);  IR (film) 1612, 1513, 
1466, 1286, 1142 cm-1;  1H NMR (400 MHz, CDCl3)  7.09 (d, J = 8.8 Hz, 2H), 6.85 (d, J = 8.8 
Hz, 2H), 6.04 (ddd, J = 16.8, 10.4, 6.8 Hz, 1H), 5.34 (d, J = 16.8 Hz, 1H), 5.21 (d, J = 10.4 Hz, 
1H), 3.79 (s, 3H), 3.77 (d, J = 6.8 Hz, 1H), ), 3.09 (dd, J = 11.2, 2.4 Hz, 1H), 2.80-2.69 (m, 1H), 
2.63-2.52 (m, 1H), 2.29-2.17 (m, 1H), 1.98-1.85 (m, 1H), 1.41 (s, 9H), 1.31 (s, 9H);  13C NMR 
(100 MHz, CDCl3)  158.3, 139.2, 132.5, 129.5, 116.7, 114.2, 60.1, 59.4, 57.1, 56.9, 55.5, 37.5, 
31.6, 29.0, 28.8;  HRMS calcd. for C21H34N2NaO3S (M+Na)+: 417.2182.  Found: 417.2195. 
 
 
Table 4.1, entry 11 (rc_b8_6_11) 
 
Pale yellow oil;  [α]20D= +21.7 (c 0.83, CHCl3) (93% ee);  IR (film) 1468, 1296, 1145 cm-1;  1H 
NMR (400 MHz, CDCl3)  6.08 (ddd, J = 16.8, 10.4, 6.4 Hz, 1H), 5.44 (d, J = 16.8 Hz, 1H), 
5.25 (d, J = 10.4 Hz, 1H), 4.15 (d, J = 6.4 Hz, 1H), 3.61-3.48 (m, 2H), 3.47-3.38 (m, 2H), 3.33 
(dd, J = 10.8, 4.4 Hz, 1H), 1.65-1.53 (m, 2H), 1.43 (s, 9H), 1.40 (s, 9H), 1.40-1.22 (m, 6H), 0.90 
(t, J = 6.4 Hz, 3H);  13C NMR (75 MHz, CDCl3)  139.0, 117.1, 71.7, 58.8, 58.1, 57.1, 31.8, 
115 
 
29.7, 28.9, 28.8, 26.1, 22.8, 14.2;  HRMS calcd. for C19H38N2NaO3S (M+Na)+: 397.2495.  
Found: 397.2488. 
 
Table 4.1, entry 12 (rc_b8_28_8) 
 
White solid;  mp 80-82 oC; [α]20D= +42.6 (c 0.97, CHCl3) (93% ee);  IR (film) 1600, 1498, 1398, 
1295, 1144 cm-1;  1H NMR (300 MHz, CDCl3)  7.38-7.25 (m, 2H), 7.03-6.90 (m, 3H), 6.14 
(dddd, J = 16.8, 10.2, 6.3, 0.9 Hz, 1H), 5.50 (dd, J = 16.8, 0.9 Hz, 1H), 5.31 (dd, J = 10.2, 0.9 
Hz, 1H), 4.21 (d, J = 6.3 Hz, 1H), 4.12 (t, J = 9.6 Hz, 1H), 3.95 (dd, J = 9.6, 3.9 Hz, 1H), 3.57 
(dd, J = 10.2, 3.9 Hz, 1H), 1.43 (s, 9H), 1.39 (s, 9H);  13C NMR (75 MHz, CDCl3)  158.3, 
138.5, 129.9, 121.7, 117.6, 114.8, 68.6, 58.6, 58.3, 57.35, 57.30, 28.9, 28.7;  Anal. calcd. for 
C19H30N2O3S: C, 62.26; H, 8.25; N, 7.64.  Found: C, 62.58; H, 8.08; N, 7.67. 
 
Table 4.1, entry 13 (rc_b8_34_2) 
 
Colorless oil;  [α]20D= +28.9 (c 0.61, CHCl3) (91% ee);  IR (film) 1644, 1398, 1291 cm-1;  1H 
NMR (300 MHz, CDCl3)  6.06 (ddd, J = 17.1, 10.5, 6.9 Hz, 1H), 5.33 (d, J = 17.1, Hz, 1H), 
5.18 (d, J = 10.5 Hz, 1H), 3.99 (d, J = 6.9 Hz, 1H), 3.72-3.61 (m, 2H), 3.31 (dd, J = 10.5, 2.4 Hz, 
1H), 2.15-2.00 (m, 1H), 1.85-1.72 (m, 1H), 1.37 (s, 9H), 1.35 (s, 9H), 0.08 (s, 9H);  13C NMR 
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(75 MHz, CDCl3)  139.4, 116.6, 60.7, 59.7, 58.6, 57.1, 56.9, 38.5, 29.0, 28.9, -0.47;  Anal. 
calcd. for C17H36N2O3SSi: C, 54.21; H, 9.63; N, 7.44.  Found: C, 54.02; H, 9.38; N, 7.55. 
 
Table 4.1, entry 14 (rc_b8_6_6) 
 
Colorless oil;  [α]20D= +25.0 (c 0.46, CHCl3) (91% ee);  IR (film) 1644, 1289, 1142 cm-1;  1H 
NMR (300 MHz, CDCl3)  6.04 (ddd, J = 16.8, 9.9, 6.6 Hz, 1H), 5.57-5.44 (m, 1H), 5.42-5.30 
(m, 1H), 5.34 (d, J = 16.8 Hz, 1H), 5.19 (d, J = 10.2 Hz, 1H), 3.78 (d,  J = 7.2 Hz, 1H), 3.13 (dd, 
J = 11.1, 2.7 Hz, 1H), 2.22-1.88 (m, 5H), 1.74-1.56 (m, 1H), 1.39 (s, 9H), 1.37 (s, 9H), 0.95 (t, J 
= 7.2 Hz, 3H);  13C NMR (75 MHz, CDCl3)  139.4, 134.0, 127.3, 116.5, 59.9, 59.5, 57.1, 56.9, 
35.5, 29.2, 28.9, 25.7, 14.0;  Anal. calcd. for C18H34N2O2S: C, 63.11; H, 10.00; N, 8.18.  Found: 
C, 63.34; H, 9.89; N, 7.93. 
 
Table 4.1, entry 15 (rc_b8_6_5) 
 
Colorless oil;  [α]20D= +27.2 (c 1.2, CHCl3) (91% ee);  IR (film) 1727, 1644, 1398, 1290, 1143 
cm-1;  1H NMR (300 MHz, CDCl3)  6.06 (ddd, J = 17.1, 10.2, 6.9 Hz, 1H), 5.52-5.24 (m, 2H), 
5.36 (d, J = 17.1 Hz, 1H), 5.21 (d, J = 10.2 Hz, 1H), 3.79 (d, J = 6.9 Hz, 1H), 3.11 (dd,  J = 10.8, 
2.4 Hz, 1H), 2.24-1.90 (m, 5H), 1.74-1.58 (m, 1H), 1.41 (s, 9H), 1.38 (s, 9H), 0.97 (t, J = 7.8 Hz, 
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3H);  13C NMR (75 MHz, CDCl3)  139.4, 133.3, 127.2, 116.7, 60.1, 59.7, 57.1, 56.9, 35.8, 29.0, 
28.9, 23.7, 20.8, 14.4;  Anal. calcd. for C18H34N2O2S: C, 63.11; H, 10.00; N, 8.18.  Found: C, 
62.83; H, 9.82; N, 7.96. 
 
Scheme 4.7 (rc_b9_38_2) 4-23d 
 
Yellow Oil; [α]20D= +25.6 (c 0.5, CHCl3) (91% ee);  IR (film) 3255, 1302, 1168 cm-11H NMR 
(300 MHz, CDCl3)  5.80 (ddd, J = 16.8, 10.5, 7.5 Hz, 1H), 5.40 (d, J = 16.8 Hz, 1H), 5.33 (d, J 
= 10.5 Hz, 1H), 4.61 (d, J = 6.0 Hz, 1H), 4.54 (d, J = 8.4 Hz, 1H), 3.96-3.80 (m, 1H), 3.52-3.41 
(m, 1H), 1.75-1.24 (m, 8H), 0.89 (t, J = 6.9 Hz, 3H);  13C NMR (100 MHz, CDCl3)  133.8, 
120.8, 66.4, 63.0, 32.3, 31.6, 26.4, 22.6, 14.1;  Anal. calcd. for C9H18N2O2S:  C 49.51, H 8.31, N 
12.83;  found:  C 49.43, H 8.11, N 12.90.  
Cornwall, R.G.; Zhao, B.; Shi, Y. Org. Lett. 2011, 13, 434. 
 
Scheme 4.7 (rc_b9_38) 4-24d 
 
Pale yellow oil;  [α]20D= +29.5 (c 0.84, CHCl3) (91% ee);  IR (film) 3369, 3593, 2927, 2857, 
1466 cm-1;  1H NMR (400 MHz, CDCl3)  5.84 (ddd, J = 12.6, 7.5, 4.8, 1H), 5.19 (d, J = 12.6 
Hz, 1H), 5.12 (d, J = 7.5 Hz, 1H), 3.17 (t, J = 4.8, 1H), 2.61 (dd, J = 6.0, 3.3, 1H), 1.57-1.40 (m, 
2H), 1.38-1.16 (m, 10H), 0.90 (t, J = 4.8);  13C NMR (100 MHz, CDCl3)  141.7, 115.0, 59.2, 
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55.7, 34.6, 32.2, 26.4, 22.9, 14.3. 
Zhao, B.; Peng, X.; Cui, S.; Shi, Y. J. Am. Chem. Soc. 2010, 132, 11009. 
 
Scheme 4.7 (rc_b9_38_2) 4-23h 
 
White solid;  mp 77-79 oC;  [α]20D= +24.3 (c 0.75, CHCl3) (93% ee);  IR (film) 3261, 1497, 1167 
cm-1,  1H NMR (300 MHz, CDCl3)  7.40-7.19 (m, 5H), 5.76 (ddd, J = 17.1, 9.9, 7.2 Hz, 1H), 
5.38 (d, J = 17.1 Hz, 1H), 5.29 (d, J = 9.9 Hz, 1H), 4.85 (d, J = 6.0 Hz, 1H), 4.67 (d, J = 7.2 Hz, 
1H), 4.10-3.96 (m, 1H), 3.80-3.65 (m, 1H), 2.99 (dd, J = 14.1, 4.8 Hz, 1H), 2.88 (dd, J = 14.1, 
8.7 Hz, 1H);  13C NMR (75 MHz, CDCl3)  136.6, 133.6, 129.3, 129.0, 127.3, 120.7, 64.9, 63.5, 
38.4.  HRMS calcd. for C11H15N2O2S (M+H+): 239.0849.  Found: 239.0847. 
 
Scheme 4.7 (rc_b9_38) 4-24h 
 
Pale yellow oil;  [α]20D= +43.7 (c 0.71, CHCl3) (93% ee);  IR (film) 3374, 3295, 1639, 1602, 
1495, 1453 cm-1;  1H NMR (400 MHz, CDCl3)  7.35-7.28 (m, 2H), 7.25-7.19 (m, 3H), 5.92 
(ddd, J = 17.2, 10.4, 6.4 Hz, 1H), 5.25 (d, J = 17.2 Hz, 1H), 5.18 (d, J = 10.4 Hz, 1H), 3.29-3.22 
(m, 1H), 2.99-2.89 (m, 2H), 2.50 (dd, J = 14.4, 10.4 Hz, 1H), 1.18 (brs, 4H);  13C NMR (100 
MHz, CDCl3)  141.5, 139.8, 129.4, 128.7, 126.5, 115.4, 58.7, 57.1, 41.2. 
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CHAPTER 5.0: OTHER THIADIAZIRIDINE USES 
 
5.1 Pd(II)-CATALYZED TERMINAL DIAMINATION 
5.1.1 Background 
 As discussed in Chapter 3, diamination of terminal olefins using Pd and thiadiaziridine 3-
1 resulted in overall dehydrogenative diamination (Scheme 5.1).1 In a related reaction, it was 
also shown that under the same reaction conditions and with a conjugated diene as substrate, a 
mixture of internal and terminal diamination products was observed. Because Pd was thought to 
only provide internal diamination of diene substrates, it was of interest to investigate how 
terminal diamination could be obtained using Pd as catalyst.  
 
Scheme 5.1 
5.1.2 Results and Discussion 
 Using 1-phenyl-1,3-butadiene as substrate, various Pd catalysts were screened (Table 
5.1). Both Pd(II) (Table 5.1, entries 1-7) as well as Pd(0) (Table 5.1, entries 8-10) gave good 
conversions but PdCl2(MeCN)2 provided the highest conversion and exclusive terminal 
diamination in 30% yield (Table 5.1, entry 6).2 Upon screening ligands for the reaction, 
conversions were lowered, apparently hindering the reaction. When diisopropyl ethylamine was 
added, conversion increased to 100%, but yield remained at 30%. It was also noticed that upon 
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addition of sulfur urea, the reaction sped up (Scheme 5.2). Using only tert-butylsulfamide, 
without thiadiaziridine 3-1, however resulted in no reaction. 
 
Table 5.1 Pd Screening for Terminal Diamination of Conjugated Dienes 
 
Entry Catalyst Conversion Selectivity (5-1a : 5-1b) 
1 PdCl2 50 1 : 0 
2 Pd(OAc)2 18 - 
3 PdI2 4 - 
4 Pd(TFA)2 65 1.1 : 1 
5 PdCl2(CNPh)2 56 1 : 0 
6 PdCl2(MeCN)2 83 (30% yield) 1 : 0 
7 PdCl2(cod) 67 1 : 0 
8 Pd(dppe)2 0 - 
9 Pd2(dba)3 28 1 : 0 






5.1.3 Mechanistic Hypothesis 
 Using the above observations, the following mechanism was hypothesized (Scheme 5.3).  
The Pd(II) catalyst complexes with the conjugated diene to give 5-2 whereupon nucleophilic 
attack of tert-butylsulfamide (5-3) gives π-allyl Pd(II) complex 5-4. Addition of the second 
nitrogen closes the ring to form product 5-1a and generates Pd(0) and HCl. Thiadiaziridine 3-1 
acts as an oxidant to oxidize Pd(0) back to Pd(II) , regenerating the active catalyst. Addition of 
base (ie. diisopropyl ethylamine) is beneficial to the reaction as is could serve to deprotonate the 




Polymerization was a major problem and attempts to decrease polymerization and increase yield 
via drop-wise addition of 3-1 and lower reaction temperature, were unsuccessful. Addition of 5 
mol% benzoquinone however increased yield to 40%. The reaction parameters screened as well 
as the proposed mechanism was very similar to those reported by Lloyd-Jones, Booker-Milburn 
and coworkers3 and therefore, this project was pursued no further. 
5.2 METAL-CATALYZED DIAMINATION OF ALLENES 
5.2.1 Results and Discussion 
 Of the many methods to synthesize vicinal diamines, the synthesis of cis-diamines 
presents an especially unique challenge. It was proposed that cis-diamines could be obtained via 




Diamination conditions involving nitrogen sources 1-17 and 3-1, as well as both Pd and Cu 
catalysts are summarized in Table 5.2.4 Diaziridinone 1-17 showed little to no reactivity with Pd 
or Cu catalysts. Thiadiaziridine 3-1 also displayed little to no reactivity with electron 
withdrawing allenes but the electron donating methoxy allene gave 100% conversion under both 
Pd and Cu catalysis conditions. The internal diamination product was inferred based on 1H NMR 
analysis of the purified product. The product was stable enough for purification on silica gel 
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however, it is likely acid sensitive. Judging from these results, the diamination of allenes is an 
interesting project but at this time is likely limited in scope/applicability. 
Table 5.2 Diamination of Allenes 










Decomp NR NR Decomp NR NR 
 



















5.3 OXIDATION OF ALCOHOLS 
5.3.1 Background 
 The Saegusa oxidation is a well-known organic reaction for the efficient conversion of 
silyl enol ethers to the corresponding α,β-unsaturated carbonyls and remains a leading method 
for the synthesis of α,β-unsaturated carbonyls (Scheme 5.5).5 Recently, Shi and coworkers have 
reported alternative uses for diaziridinone 1-17 as an oxidative reagent such as mediating the 
coupling of anilines to form azo compounds and hydrazines,6 as well as the Cu(I)-catalyzed 
oxidation of alcohols to ketones and aldehydes (Figure 5.1).7 A variety of primary and secondary 
alcohols can be smoothly oxidized using CuBr as catalyst to give the corresponding aldehydes 






5.3.2 Result and Discussion 
 Along the same lines employing diaziridinone and thiadiaziridine as oxidizing reagents, it 
was envisioned that the dehydrogenation of carbonyls could be accomplished. Cyclohexanone 
was employed to test this hypothesis (Table 5.3).8 Good conversion was obtained using Pd as 
catalyst with either oxidant; however, separation of the starting material, product and urea 




Table 5.3 Initial Screening for Oxidation of Cyclohexanone 
 














Acyclic ketone 1,3-diphenylpropanone (5-5a), was converted to chalcone (5-6a) in 67% 
conversion and separation on silica gel chromatography using Pentane:Et2O 100:1 gave the pure 




Catalyst loading was investigated next and any lowering from 10 mol% Pd(PPh3)4 resulted in 
diminished conversion. Screening of the addition of various phosphorus ligands also resulted in 
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diminished reactivity.  Slow addition of thiadiaziridine 3-1 produced a noticeable increase in 
conversion and upon raising the reaction temperature to 85 oC, the catalyst loading could be 
reduced to 5 mol%. The oxidation of 1,3-diphenylpropanone (5-5a) was accomplished in 72% 
yield (Table 5.4, Entry 1).9 Unfortunately, without aryl groups at the R1 and R3 positions, no 
reaction took place (Table 5.4, entries 2,3). Sterically bulky 5-5d was very reactive and oxidation 
occurred cleanly in 81% yield (Table 5.4, entry 4). Cyclic ketones also provided good 
conversion, however separation and volatility made purification difficult (Table 5.4, entries 5,6). 
α-Substitution also diminished reactivity (Table 5.4, entries 8,9). α-Methyl cyclohexanone was 
selectively oxidized at the least hindered position, albeit in 43% conversion (Table 5.4, entry 9). 
The oxidation of aldehydes was also investigated (Table 5.4, entries 10-14). 3-Phenylpropanal 
(5-5j) was oxidized in 100% conversion and 5-hexanal (5-5l) and isobutyraldehyde (5-5n) were 
oxidized in ~50% conversion, whereas other aldehydes screened gave no conversion. It is known 
that acyclic ketones and aldehydes are less reactive than their cyclic counterparts and it is 









Table 5.4 Oxidation to α,β-Unsaturated Carbonylsa 
 








5-5a, R1,R3= Ph, R2= H 
5-5b, R1= CH3, R2= H, R3= Ph 
5-5c, R1,R3= CH3, R2= H 















5-5e, X= CH2 
5-5f, X= O 






















5-5j, R= Ph 
5-5k, R= H 
5-5l, R= Et 












14 5-5n 5-6n 50 
a All reactions were carried out with ketone or aldehyde 5-5 (0.40 mmol), Pd(PPh3)4 (0.020 
mmol) in toluene (0.1 mL) at 85 oC with slow addition of 3-1 (0.6 mmol) for 24 h, unless 
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otherwise stated. Entries 5,6,10-14 were carried out at 65 oC. For entries 11-14, 3-1 was added in 
one portion. 
 
It was also observed that the oxidation from alcohols to α,β-unsaturated carbonyls could be 
accomplished using 2.5 equivalents of oxidant 3-1 (Scheme 5.7).10 Employing Pd(PPh3)4 as 
catalyst and 2.5 equivalents of oxidant 3-1 at 65 oC gave cyclohexenone in 77% conversion. 1,3-
diphenyl-1-propanol was also oxidized directly to chalcone, but a complex mixture of products 




 Thiadiaziridine 3-1 is a highly effective diamination reagent to install vicinal diamine 
functionality across olefins employing Pd or Cu as catalyst. This versatility is demonstrated by 
Pd(II)-catalyzed terminal diamination of conjugated dienes and Pd(0) or Cu(I)-catalyzed 
diamination of electron-rich allenes. The oxidation of alcohols and ketones/aldehydes to the 
corresponding α,β-unsaturated carbonyls using 3-1 as oxidant demonstrates the untapped 
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Appendix 3 Spectra for Chapter 4 
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Table 4.1, entry 1 
 
HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical Industries, 









Table 4.1, entry 2 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 











Table 4.1, entry 3 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 










Table 4.1, entry 4 
231 
 
HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 











Table 4.1, entry 5 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 
















Table 4.1, entry 6 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 









Table 4.1, entry 7 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 
Industries, Ltd. Eluent: Hexanes/IPA (70/30); Flow rate: 1.0 mL/min; Detection: UV210 
 








Table 4.1, entry 8 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 














HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-NJ016), Daicel Chemical 
Industries, Ltd. Eluent: Hexanes/IPA (80/20); Flow rate: 1.0 mL/min; Detection: UV200 
 













HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-NJ016), Daicel Chemical 
Industries, Ltd. Eluent: Hexanes/IPA (80/20); Flow rate: 1.0 mL/min; Detection: UV230 
 









Table 4.1, entry 11 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 










Table 4.1, entry 12 
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HPLC Conditions: Column: Chiralpak IA (Column No. IA00CE-ML034), Daicel Chemical 









Table 4.1, entry 13 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 










Table 4.1, entry 14 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 










Table 4.1, entry 15 
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HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-MJ032), Daicel Chemical 













HPLC Conditions: Column: Chiralpak OD-H (Column No. ODHOCE-FB013), Daicel 















HPLC Conditions: Column: Chiralpak IA (Column No. IC00CE-NJ016), Daicel Chemical 
Industries, Ltd. Eluent: Hexanes/IPA (90/10); Flow rate: 1.0 mL/min; Detection: UV254 











HPLC Conditions: Column: Chiralpak IC (Column No. IC00CE-NJ016), Daicel Chemical 
Industries, Ltd. Eluent: Hexanes/IPA (95/5); Flow rate: 1.0 mL/min; Detection: UV220 
 






















































































































































Table 1.  Crystal data and structure refinement for 4-22g 
Identification code  ys200 
301 
Empirical formula  C17 H36 N2 O2 S Si 
Formula weight  360.63 
Temperature  100(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P21 21 21 
Unit cell dimensions a = 10.963(3) Å = 90∞. 
 b = 11.569(4) Å = 90∞. 
 c = 17.410(5) Å  = 90∞. 
Volume 2208.0(12) Å3 
Z 4 
Density (calculated) 1.085 Mg/m3 
Absorption coefficient 0.211 mm-1 
F(000) 792 
Crystal size 0.43 x 0.39 x 0.35 mm3 
Theta range for data collection 2.11 to 28.43°. 
Index ranges -14<=h<=14, -14<=k<=15, -23<=l<=23 
Reflections collected 44743 
Independent reflections 5432 [R(int) = 0.0255] 
Completeness to theta = 28.43∞ 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.9291 and 0.9150 
Refinement method Full-matrix least-squares on F2 
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Data / restraints / parameters 5432 / 0 / 217 
Goodness-of-fit on F2 1.034 
Final R indices [I>2sigma(I)] R1 = 0.0312, wR2 = 0.0857 
R indices (all data) R1 = 0.0360, wR2 = 0.0892 
Absolute structure parameter 0.00(6) 
Largest diff. peak and hole 0.171 and -0.150 e.Å-3 
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 Table 2.  Atomic coordinates  ( x 104) and equivalent  isotropic displacement parameters (≈2x 103) 
for ys200.  U(eq) is defined as one third of  the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________  
 x y z U(eq) 
________________________________________________________________________________   
C(1) 7214(2) 9233(3) 4160(1) 98(1) 
C(2) 5652(3) 10531(2) 5341(1) 93(1) 
C(3) 6118(3) 7950(2) 5527(1) 99(1) 
C(4) 4486(2) 8816(1) 4226(1) 51(1) 
C(5) 4085(1) 9800(1) 3692(1) 44(1) 
C(6) 3100(1) 9448(1) 3110(1) 40(1) 
C(7) 3615(1) 8701(1) 2446(1) 39(1) 
C(8) 2693(2) 7827(1) 2155(1) 56(1) 
C(9) 2176(2) 7823(2) 1478(1) 72(1) 
C(10) 1318(1) 10926(1) 2939(1) 49(1) 
C(11) 321(2) 10167(2) 2616(2) 85(1) 
C(12) 1194(2) 12179(2) 2658(1) 74(1) 
C(13) 1246(2) 10965(2) 3822(1) 81(1) 
C(14) 5182(1) 9436(1) 1435(1) 49(1) 
C(15) 6234(2) 9777(2) 1969(1) 74(1) 
C(16) 5339(2) 8175(2) 1184(1) 69(1) 
C(17) 5154(2) 10195(2) 717(1) 81(1) 
N(1) 3981(1) 9538(1) 1851(1) 40(1) 
304 
N(2) 2553(1) 10459(1) 2725(1) 44(1) 
O(1) 4087(1) 11705(1) 2007(1) 63(1) 
O(2) 2375(1) 10915(1) 1309(1) 68(1) 
S(1) 3239(1) 10763(1) 1920(1) 42(1) 
Si(1) 5871(1) 9140(1) 4819(1) 57(1) 
________________________________________________________________________________ 
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 Table 3.   Bond lengths [≈] and angles [∞] for  ys200. 
_____________________________________________________  
C(1)-Si(1)  1.870(2) 
C(2)-Si(1)  1.865(2) 
C(3)-Si(1)  1.866(2) 
C(4)-C(5)  1.534(2) 
C(4)-Si(1)  1.8744(17) 
C(5)-C(6)  1.5360(19) 
C(6)-N(2)  1.4760(16) 
C(6)-C(7)  1.5500(19) 
C(7)-N(1)  1.4733(17) 
C(7)-C(8)  1.516(2) 
C(8)-C(9)  1.307(3) 
C(10)-N(2)  1.5042(18) 
C(10)-C(11)  1.510(3) 
C(10)-C(12)  1.536(2) 
C(10)-C(13)  1.541(3) 
C(14)-N(1)  1.5078(18) 
C(14)-C(17)  1.527(2) 
C(14)-C(15)  1.532(3) 
C(14)-C(16)  1.533(2) 
N(1)-S(1)  1.6381(12) 
N(2)-S(1)  1.6287(12) 
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O(1)-S(1)  1.4407(12) 











































Symmetry transformations used to generate equivalent atoms:  
Table 4.   Anisotropic displacement parameters  (≈2x 103) for ys200.  The anisotropic 
displacement factor exponent takes the form:  -22[ h2 a*2U11 + ...  + 2 h k a* b* U12 ] 
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______________________________________________________________________________  
 U11 U22  U33 U23 U13 U12 
______________________________________________________________________________  
C(1) 64(1)  150(3) 79(1)  -24(2) -13(1)  -11(2) 
C(2) 139(2)  72(1) 68(1)  -20(1) -30(1)  23(1) 
C(3) 133(2)  79(2) 85(2)  13(1) -48(2)  24(2) 
C(4) 56(1)  50(1) 48(1)  8(1) -6(1)  5(1) 
C(5) 48(1)  41(1) 42(1)  3(1) -1(1)  6(1) 
C(6) 37(1)  38(1) 43(1)  9(1) 2(1)  2(1) 
C(7) 38(1)  33(1) 45(1)  4(1) -1(1)  0(1) 
C(8) 56(1)  37(1) 76(1)  0(1) 6(1)  -11(1) 
C(9) 62(1)  66(1) 88(1)  -15(1) -10(1)  -21(1) 
C(10) 41(1)  48(1) 59(1)  5(1) 5(1)  11(1) 
C(11) 46(1)  84(1) 127(2)  -18(1) 5(1)  -2(1) 
C(12) 67(1)  54(1) 102(2)  11(1) 14(1)  24(1) 
C(13) 77(1)  100(2) 66(1)  8(1) 23(1)  37(1) 
C(14) 51(1)  50(1) 47(1)  -5(1) 14(1)  -2(1) 
C(15) 42(1)  94(1) 85(1)  -20(1) 11(1)  -10(1) 
C(16) 74(1)  57(1) 77(1)  -16(1) 22(1)  6(1) 
C(17) 108(2)  80(1) 56(1)  13(1) 35(1)  9(1) 
N(1) 42(1)  35(1) 42(1)  2(1) 4(1)  0(1) 
N(2) 42(1)  44(1) 46(1)  11(1) 6(1)  11(1) 
O(1) 71(1)  38(1) 79(1)  -2(1) 20(1)  -10(1) 
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O(2) 79(1)  76(1) 49(1)  12(1) -11(1)  22(1) 
S(1) 49(1)  34(1) 41(1)  6(1) 2(1)  2(1) 
Si(1) 68(1)  58(1) 45(1)  -4(1) -17(1)  12(1) 
______________________________________________________________________________  
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic  displacement parameters (≈2x 10 3) 
for ys200. 
________________________________________________________________________________  
 x  y  z  U(eq) 
________________________________________________________________________________  
  
H(1A) 7202 9961 3896 146 
H(1B) 7177 8616 3792 146 
H(1C) 7953 9169 4453 146 
H(2A) 4841 10560 5550 139 
H(2B) 5765 11165 4992 139 
H(2C) 6235 10587 5751 139 
H(3A) 6861 8087 5804 149 
H(3B) 6173 7226 5260 149 
H(3C) 5446 7926 5880 149 
H(4A) 4648 8135 3917 62 
H(4B) 3815 8632 4569 62 
H(5A) 4793 10080 3414 52 
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H(5B) 3777 10432 4002 52 
H(6) 2458 9014 3376 47 
H(7) 4341 8289 2628 47 
H(8) 2473 7238 2491 67 
H(9A) 2367 8395 1123 87 
H(9B) 1619 7247 1352 87 
H(11A) 386 10144 2067 128 
H(11B) -460 10476 2758 128 
H(11C) 404 9400 2819 128 
H(12A) 1250 12198 2108 111 
H(12B) 1836 12639 2875 111 
H(12C) 419 12484 2815 111 
H(13A) 455 11237 3976 122 
H(13B) 1861 11479 4016 122 
H(13C) 1378 10204 4025 122 
H(15A) 6264 9252 2396 111 
H(15B) 6107 10549 2154 111 
H(15C) 6990 9742 1692 111 
H(16A) 4681 7962 848 104 
H(16B) 5333 7683 1628 104 
H(16C) 6101 8089 918 104 
H(17A) 5902 10102 437 122 
H(17B) 5062 10990 865 122 
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H(17C) 4480 9971 399 122 
________________________________________________________________________________   
 
 
